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Abstract 
 
The idea of utilizing nanomaterials in bio-related applications has been extensively practiced 
during the recent decades. Magnetic nanoparticles (MPs), especially superparamagnetic iron 
oxide nanoparticles have been demonstrated as promising candidates for biomedicine. A 
protective coating process with biocompatible materials is commonly performed on MPs to 
further enhance their colloidal and chemical stability in the physiological environment. 
Mesoporous hollow silica is another class of important nanomaterials that are extensively studied 
in drug delivery area for their ability to carry significant amount of guest molecules and release 
in a controlled manner. 
 
In this study, different synthetic approaches that are able to produce hybrid nanomaterials, 
constituting both mesoporous hollow silica and magnetite nanoparticles, are described.  In a two-
step approach, pre-synthesized magnetite nanoparticles are either covalently conjugated to the 
surface of polystyrene beads and coated with silica or embedded/enclosed in the porous shell 
during a nanosized CaCO3 templated condensation of silica precursors, followed by acid 
dissolution to generate the hollow structure.  It was demonstrated that the hollow interior is able 
to load large amount of hydrophobic drugs such as ibuprofen while the mesoporous shell is 
capable of prolonged drug. In order to simplify the fabrication procedure, a novel in-situ method 
is developed to coat silica surface with magnetite nanoparticles. By refluxing the iron precursor 
with mesoporous hollow silica nanospheres in polyamine/polyalcohol mixed media, one is able 
to directly form a high density layer of magnetite nanoparticles on silica surface during the 
synthesis, leaving reactive amine groups for further surface functionalization such as 
fluorescence conjugation. This approach provides a convenient synthesis for silica nanostructures 
with promising potential for drug delivery and multimodal imaging. 
 
In addition to nanoparticles, nanowires also benefit the research and development of 
instruments in clinical diagnosis. Semiconductive nanowires have demonstrated their advantage 
in the fabrication of lab-on-a-chip devices to detect many charge carrying molecules such as 
antibody and DNA. In our study, In2O3 and silicon nanowire based field effect transistors were 
fabricated through bottom-up and top-down approaches, respectively, for ultrasensitive bio- 
detection of toxins such as ricin. The specific binding and non-specific interaction of nanowires 
with antibodies were also investigated. 
 
Mesoporous hollow silica, Magnetic nanoparticle, Drug delivery, Field-effect transistor biosensor, 
In2O3 nanowire, Silicon nanowire. 
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Part One: Magnetic Hollow Mesoporous Silica Nanostructures for Bio-
medicine Application 
 
Chapter I: Introduction 
 
Amorphous silica material has been widely exploited in various applications such as 
adsorption and separation of impurity, catalysis and drug delivery. Nanosized mesoporous silica 
structures feature in many outstanding advantages in the field of bio-medicine and bio-
engineering including bio-compatibility, low toxicity, highly designable morphology and large 
surface area providing excellent platform for drug loading and modification of further 
functionalities. Uniform mesoporous silica particles are usually obtained by ordered self 
assembly of surfactant molecules integrated with silica precursors. Subsequently, methods such 
as soft/hard template and selective etching are fast developing techniques for synthesizing 
mesoporous silica with hollow interior which has been demonstrated to be more efficient for 
drug loading due to increased surface area and nanochannels connecting exterior and interior 
surface.
1
 Based on the foundation of mesoporous silica, decoration with superparamagnetic iron 
oxide nanoparticles (SPION) is one of the most popular research concentrations for the purpose 
of targeted drug delivery, MRI contrast enhancement, hyperthermia treatment and other potential 
biomedicine applications. Furthermore, by combining with features like fluorescence, plasmonic 
resonance and targeting biological molecules conjugation, numerous designs of multi-functional 
silica nanostructure have been reported to achieve the best platform for targeted imaging and 
drug delivery in the diagnosis and treatment for infection, cancer and genetic diseases.  
In this chapter, a review of several representative categories of mesoporous silica 
nanostructures with and without hollow interior is provided. Then various approaches of 
2 
 
attaching or integrating SPION to silica nanoparticles, either in the core area, embedded in the 
shell or conjugated on surface, are introduced. At last, further particle engineering modifications 
to achieve multifunctional particle for different biomedicine applications will be discussed, such 
as simple trigger drug release and fluorescence imaging. 
 
1.1 Synthesis of uniform mesoporous silica nanoparticles (MSN) 
The first reported ordered MSN was MCM-41 (Mobil Composition of Matter No. 41) 
prepared through liquid crystal template method by Mobil R&D in 1992.
2
 Ever since then, the 
synthesis of MSN with controllable morphology and potential functionalization has been 
drawing extensive attention through decades. Generally speaking, MSN materials are 
synthesized from the self-assembly of surfactants which serve as structure-directing template, 
followed by the hydrolysis and condensation of silica precursor with opposite charge around the 
surfactants.
3
 Based on abundant available selection of surfactants and silica precursors with 
nature better understood, and fine adjustment of pH and solvents, a great variety of MSN with 
different pore size, pore structure and arrangement, as well as particle size and shape has been 
prepared. Several kinds of MSN with pore diameter from 1 to tens of nanometer are deeply 
involved in bio-medicine applications, such as MCM, TUD (Technische Universität Delft), SBA 
(Santa Barbara Amorphous), and so on. 
As mentioned before, MCM-41 was the earliest synthesized, and also the most widely 
studied MSN. By using cetyltrimethylammonium bromide (CTAB) as templating surfactant, 
tetraethyl orthosilicate (TEOS) or sodium metasilicate (Na2SiO3) as precursor which hydrolyses 
under the catalysis of alkaline, uniform mesopores in hexagonal arrangement with tunable pore 
size between 1.6-10 nm was obtained. During the synthesis in polar solvent, the amphiphilic 
3 
 
CTAB molecules would form micelles in the shape of spherical, rod-like or 2-D alignment under 
a concentration higher than a critical value (critical micelle concentration, CMC), and then 
condensation of silica precursors occurs around the polar head of the surfactant to form silica 
after hydrolysis. Surfactant template can be easily removed through either calcinations or solvent 
extraction, and the mesoporous silica is finally obtained.
2,4
  
SBA-15 is another popular MSN material that has been widely introduced for application 
such as catalysis and drug delivery. It was originally prepared through a triblock copolymer 
consisting of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) 
as structure-directing template in acidic media. Investigations of using different ratio between 
EO and PO, silica precursors (tetraethoxysilane (TEOS), tetramethoxysilane (TMOS), 
tetrapropoxysilane (TPOS)), inorganic acid and pH were conducted, resulting larger tunable pore 
sizes up to 30 nm and thicker wall. Furthermore, while the template removal can be completed 
by either calcinations or solvent extraction, the latter one allows the triblock polymer to be 
recovered for reuse.
5,6
 However, due to the nature of polymeric template, SBA-15 particles is 
restricted to only relatively larger size and rigid structure, which significantly limit the potential 
for in vivo drug delivery application.
1
 
Different from MCM and SBA, TUD-1 is a three-dimensional disordered, sponge-like 
mesoporous silica network structure synthesized from hydrolysis of TEOS with organic base 
tetraethylammonium hydroxide (TEAOH) and triethanolamine (TEA). Mesoporous silica was 
achieved by simple aggregation of the molecules without introducing surfactant template, and 
the pore size can be tunable between 2.5 nm to 25nm. The randomly arranged mesopores and 
large pore volume provide high accessibility for drug molecules and exhibit higher drug loading 
efficiency and rapid initial release (60% in 15 min for ibuprofen) by comparing with MCM-41. 
4 
 
However, due to lack of surfactant directed micelle formation, the morphology of TUD-1 stays in 
amorphous instead of homogeneous nanoparticle or nanorod and less designable, which prevents 
it from in vivo application in bio-medicine.
7,8
  
 
1.2 Synthesis of hollow mesoporous silica nanoparticles 
In the recent decade, hollow mesoporous silica nanoparticle (HMSN) with void interior space 
and improved surface area has been drawing extensive attention. Comparing to conventional 
uniform MSN, the hollow interior that is easily accessible by diffusion of drug molecules 
through well ordered mesopores channels from exterior surface provides additional mesoporous 
surface for drug adsorption. Therefore the whole HMSN act as a capsule for drug molecules 
storage and the drug release is also controllable in two stages due to relatively rapid initial 
release from outer surface adsorption and slower permeation from inner void through cavities. So 
far, HMSN can be obtained by using either sacrificial templates in core area or selective etching 
inner layer of silica.
1,3
 
 
1.2.1 Hard template method for synthesizing HMSN 
Hard template method can be described as using pre-prepared nanoparticle in sol-gel process 
to direct the self-assembly of surfactant and lead the condensation of silica precursor only 
happens on around surface of the template material, and hollow interior can be achieved after 
template removal by calcination and/or solvent extract. The size of HMSN is mainly 
predetermined by the diameter of the template, and the thickness of silica shell can be tuned by 
adjusting the ration between template, surfactant and precursor. Various nanoparticle materials 
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with features such as good dispersity, homogeneous size, easy synthesis and low cost have been 
selected as the sacrificial template.  
Polystyrene (PS) nanoparticle is the most widely used hard template for HMSN synthesis. 
The preparation of monodispersed PS latex is a well established technique through 
microemulsion or emulsifier-free process within oil-in-water system with monomer styrene and 
polymerization inducer like potassium persulfate (K2S2O8). So far the available particle size 
varies from several nanometers to microns, which provides large selection for synthesis of 
HMSN with different diameter. Also, the functionalization of PS particles can be completed by 
blending in other comonomers such as acrylic acid, or functional surfactant sodium dodecyl 
sulfate (SDS) during the polymerization of styrene to achieve functionalities of amine, carboxyl, 
thiol, sulfate and so on, in order to further improve and monodispersity and stability of the 
particles.
9-12
 The process of silica coating on PS is usually carried out in the mixed media of 
ethanol and water under ammonia catalysis, the template removal can be achieved by calcination 
or solvent extraction using toluene, chloroform and dichloromethane.
13-15
 
Several other nanosized organic compounds have also been applied for templating the 
formation of hollow silica structure. Solid lipid nanoparticles (SLN) has been demonstrated to be 
a promising material for hydrophobic drug delivery due to the advantage of facile synthesis, easy 
drug loading, low toxicity, highly bio-compatibility and bio-degradability.
16
 HMSN prepared 
from cetylpalmitate SLN was obtained with size around 500 nm and present promising potential 
in pharmaceutics applications.
17
 In addition, recently polysaccharide materials such as cellulose
18
 
and chitosan
19
 are also reported as the template for HMSN synthesis. 
Among inorganic materials, hematite (Fe2O3) has also been used for the synthesis of HMSN. 
Spherical and spindle shaped hematite was first prepared from ferric chloride in low acidic 
6 
 
aqueous solution.
20,21
 In water/isopropyl alcohol mixed media and catalysis of ammonia, 
different amount of precursor TEOS and surfactant n-octadecyl-trimethoxysilane (C18TMS) 
mixture with fixed molar ratio was then applied to obtain silica shell thickness from 8 to 30 nm, 
followed by acid etching to remove hematite.
22
 Also, calcium carbonate (CaCO3) nanoparticles 
and nanoneedles prepared from industrial apparatus have been chosen as the template to 
synthesize hollow mesoporous silica nanospheres and nanotubes, respectively.
23,24
 In addition, 
CTAB modified PbS nanocubes with good monodispersity was employed for the synthesis of 
mesoporous silica nanocages.
25
 
 
1.2.2 Soft template method for synthesizing HMSN 
Soft template method is based on using multiple surfactants or oil/water phase different to 
form a water or organic droplet in the core area and then the condensation of silica precursor 
would happen on the surface to form silica shell. It is usually a one-pot procedure without a 
separated step for template preparation. One approach to soft template synthesis is co-templating 
which employs more than one layer of surfactant formed self-assembly to build vesicle in the 
core. A cationic-anionic-neutral block copolymer ternary surfactant system was studied to 
achieve HMSN. Aqueous solutions of cationic surfactant CTAB and anionic SDS were first 
mixed together to form dual-surfactant micelles with water droplets in it. Then tri-block 
copolymer Pluronic P123 (EO20PO70EO20) worked as outer layer surfactant to anchor on the 
micelle surface, direct the formation mesoporous silica shell and prevent aggregation in slightly 
acidic condition. After template removal by calcination, the resulted HMSN present diameter 
between 100 to 500 nm with permeable shell and uniform pore size around 5 nm.
26
 In another 
reported study, poly(vinylpyrrolidone) (PVP) was chosen as the core template to synthesize 
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HMSN with CTAB directed mesopores. The product is uniform in diameter with smaller pore 
size of 2.67 nm in hexagonal arrangement, and was demonstrated to be a promising material for 
controlled drug release.
27
 
Oil-in-water (O/W) and water-in-oil (W/O) microemulsion is another synthesis approach to 
soft template by dispersing one solvent (dispersed phase) in another (continuous phase) with 
totally opposite hydrophilicity under the assistant of surfactant to form homogeneous droplets as 
template. N,N -dimethylformamide (DMF) has been reported to be the dispersed phase of the 
O/W synthesis and the inner size of HMSN with radially orientated mesopores can be precisely 
adjusted by changing the ratio of DMF/water.
28
 In the W/O reversed microemulsion, HMSN with 
the size from 20 nm to several micron can be prepared by dispersing small amount of aqueous 
solution in cyclohexane with low polarity surfactants like Triton-100 and Igepal CO-520.
29-32
 
Based on traditional water-oil microemulsion, recently an oil-in-DEG (diethylene glycol) 
synthesis was developed. Using DEG instead of water can strictly limit the hydrolysis and 
condensation of silica precursor within the oil droplets, providing better control of particle size 
and prevent agglomeration.
33,34
 
 
1.2.3 Selective etching for synthesizing HMSN 
Pure silica and other silica-organic composite network present different structure and degree 
of crosslinking from the condensation of silica precursors. Therefore, their stability against 
various etching agent, pH or temperature is also different, which provides the platform for 
designing multiple layers core/shell structure within one single nanoparticle in order to achieve 
hollow or rattle type silica by applying selective etching on designated layer(s).
35-37
 For example, 
Stöber method is the most widely conducted method for the fabrication of solid silica. But 
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recently, it was demonstrated that the outer layer of Stöber silica exhibit much higher density and 
degree of crosslinking comparing to innermost part of the silica particle. Studies show that the 
inner silica part can be etched by either simple hot water treatment of 90°C for 30 min or 
hydrothermal process in acidic condition to obtain hollow silica structure.
38,39
 Also, the surface 
of silica can be protected by applying surfactants such as PVP against alkaline etching, resulting 
in mesoporous silica shell with void interior.
40
 And the etching process can be controlled by the 
concentration of etchant and reaction time. Similarly, another strategy is to apply a secondary 
surfactant assisted silica coating with controllable thickness on solid silica nanoparticle and only 
the core area is removed after alkaline etching due to the structural difference.
41,42
   
 
1.3 Introducing superparamagnetic iron oxide nanoparticles (SPION) to mesoporous silica 
nanoparticle (MSN)  
SPION, mainly magnetite (Fe3O4) and maghemite (γ-Fe2O3), is an important inorganic 
material that can be synthesized by several well established wet chemistry approaches including 
hydrothermal, co-precipitation, microemulsion and thermal decomposition.
43
 The 
superparamagnetism property possesses zero coercivity which allows the particle to move 
towards and stay at desired area under existence of external magnetic field and be able to move 
freely once the magnetic field is removed, and is a significant advantage for applications targeted 
drug delivery, MRI contrast enhancement, and hyperthermia theory for the treatment of 
numerous diseases including infections and tumor. While MSN is an ideal drug carrier candidate 
with good bio-compatibility, numerous studies are concentrated on the integration of these two 
materials in difference morphologies and strategies. While the most direct combination of 
SPION and MSN is through covalent linkage using surface modified silica and ligand-capped 
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magnetic nanoparticles, but always suffers from low crosslinking efficiency, complicated 
preparation of both materials and ligand exchange process of magnetic particle.
44
 During the past 
decade, various pathways for facile and convenient production of magnetic mesoporous silica 
nanostructures have been developed. 
3
  
 
1.3.1 SPION/MSN core/shell structure 
Securing SPION in the core area by covering with mesoporous silica shell can effectively 
protect the iron oxide from biological environment and therefore prevent bio-degradation. 
Originally, oleic acid capped SPIONs with homogeneous size, good crystalline structure and 
hydrophobic property is the most commonly achieved SPION through a scalable synthesis.
45
 The 
SPION is first dispersed in chloroform or hexane then introduced to aqueous solution of 
surfactant for mesoporous silica coating through oil-in-water microemulsion mechanism. Here 
the surfactant here is a dual-function agent for both stabilization of SPION and mesoporous 
directing template, and the resulted structure can be either strict SPION/MSN core/shell
46-50
 or 
SPION embedded in MSN framework in a scattered manner.
51,52
 Within the same process, other 
hydrophobic nanoparticles with different characteristics such as quantum dots
52
 can also be 
capsule together with SPION to obtain multi-functional drug carrier.  
In an alternative approach, single SPION (<20 nm) or polycrystalline SPIONs which are 
usually assembled in larger size (>100 nm) from small SPIONs, are prepared in good mono-
dispersion and only one can be trapped within each mesoporous silica shell after the sol-gel 
process with adjustable thickness. The hydrophobicity of as-prepared SPION can be converted 
by modification with surfactant for stabilization immediately prior to sol-gel mesoporous silica 
coating.
53,54
 It has been frequently reported that hydrothermally prepared SPION core from 
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diethylene glycol reaction media with diameter above 100 nm was introduced to a two-step silica 
coating process, resulting in a sandwich structure. A thin nonporous silica coating was first 
applied to totally conceal the SPION and improve hydrophilicity and stability, followed by a 
surfactant directed mesoporous shell formation for adsorption of drug molecules.
55-59
 In these 
studies, perpendicular aligned mesopores can usually be achieved, providing nanosized channels 
for mass storage and transfer in drug delivery and controlled release. Furthermore, since silica 
provide easier surface modification and better reactive group availability than SPION, 
conjugations of other functionalities such as gold nanoparticles
56,58
 and fluorescence
57
 are always 
introduced between the two silica coating procedures to achieve better efficiency, as well as 
remain protected by the secondary silica coating. 
 
1.3.2 SPION embedded in MSN framework 
Different from encapsulating pre-prepared SPIONs with mesoporous silica shell under the 
assistant of surfactants, magnetic nanoparticles can be in-situ impregnated in the porous 
framework, started by immersing MSN in solution of iron oxide precursors. Sol-gel synthesis is 
one frequently applied technique based on the thermal decomposition of organic iron precursor. 
Generally, Fe(acac)3 (iron(III) acetylacetonate) is first dissolved completely in acidic aqueous 
solution to form a sol. Then MSN is then added to the system under vigorous stirring for hours 
then dried, followed by high temperature treatment (500°C) to yield grain-like magnetic iron 
oxide. The method has been successfully applied to SBA and MCM silica with well ordered 
mesopores and mainly resulted in γ-Fe2O3.
60,61
 In addition, spherical mesoporous silica 
nanoparticles with size ranging between 0.3-3 µm and an average pore diameter of 4.6 nm was 
also used to achieve γ-Fe2O3 nanoparticles of 5 nm diameter embedded in the mesopores.
62
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Another method is to use Fe(NO3)3 as the iron precursor that is easier to penetrate through 
mesopores channels due to smaller ion size and better solubility. The obtained hematite 
nanoparticles can be further reduced to Fe3O4 by either heating under H2 or NaBH4 reduction in 
solution.
63-65
 This in-situ growth of SPION provides facile integration in mesoporous silica and 
protection against bio-degradation, leaving sufficient pore volume and surface area for further 
matter storage as drug carrier. 
 
1.3.3 Rattle type SPION core in MSN shell 
During the recent years, rattle type core/shell structure has been a popular approach for 
combining SPION with mesoporous silica nanospheres. With cavity between SPION core and 
silica shell, theses magnetic silica nanorattles possess significant advantages of both strong 
magnetization, as well as increased surface area and sustained release performance of drug 
molecules provided from hollow silica nanospheres. The first reported magnetic nanorattles 
synthesis was based on the mechanism of selective etching to achieve hollow mesoporous silica. 
Hematite core with a diameter around 100 nm was first subjected to a solid layer of silica coating 
with desired thickness, followed by a surfactant incorporated mesoporous silica coating on 
outside. The sample was then introduced to hydrothermal treatment to selectively etch away the 
solid silica layer while the mesoporous layer remains protected by surfactant, leaving the cavity 
structure. At last the surfactant was removed by calcination, followed by hydrogen reduction of 
the hematite to yield magnetite.
66,67
 Later on, triblock copolymer (EO)106(PO)70(EO)106 (denoted 
as F127) was selected as the template for building the cavity instead of solid silica. The core 
material, not limited to magnetic particle, was first stabilized by the copolymer and surfactant 
through electrostatic interaction and synergetic effect to form a core-vesicle complex. Then the 
12 
 
deposition of mesoporous silica was directed by the vesicle templating through sol-gel 
polymerization of TEOS. After the hydrolysis and condensation of TEOS which caused 
shrinkage of silica shell, the cavity of nanorattles was obtained.
68
   
Another approach to nanorattles structure is to employ a composite sacrificial template in the 
core area. Colloidal carbon spheres of 800 nm diameter with adsorbed iron precursor on surface 
were first prepared by hydrothermal treatment of glucose with FeCl3, then subject to sol-gel 
mesoporous silica coating. Hematite was originally obtained after the calcination treatment for 
carbon template removal, and then converted to magnetite under hydrogen reduction. It was 
observed that the hematite nanoparticles were initially formed at the surface of carbon spheres, 
then aggregated after calcination and resulted in polycrystalline cluster with diameter within 100 
nm. Therefore, with this size shrinkage of core material from 800 to 100 nm during carbon 
removal, a large cavity was achieved.
69-71
  
 
1.4 Further functionalization and applications of SPION/MSN  
Founded on the combination nanostructures of SPION and MSN which provides significant 
advantages in both physical and chemical aspects, including superparamagnetism, large surface 
area with mesopores, low toxicity and chemically modifiable surface, numerous studies have 
been carried out to explore potential application in bio-medicine field. An interesting observation 
revealed that magnetic silica nanoparticles that are cellular internalized are able to drive the 
suspended cells to move towards a magnet, suggesting good magnetic targeting ability.
72
  
SPION/MSN nanomaterial with further functionalization has been demonstrated to be a 
promising candidate for drug/gene delivery carriers and fluorescence imaging agents.
73
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1.4.1 Drug/gene delivery 
It is widely admitted that mesoporous silica possesses large surface area and pore volume and 
makes it a preferred candidate for high efficiency drug loading by simply immersed in solution 
and continuous releasing in physiological environment.
49
 Many drugs with poor water solubility 
have been explored to demonstrate this concept, including ibuprofen,
61,74
 doxorubicin,
75
 
docetaxel,
67
 and so on. Obvious sustained release can be achieved by comparing with the 
behavior of solid silica nanostructures or pure drug pellets.
3
 And amino group functionalized 
silica can be applied for gene delivery by absorbing oligonucleotide through electronic 
interaction to reach into tumor cell.
76
 
Other than physical absorption, many groups have been focusing on designing the covalent 
binding between drug molecules and silica surface that can be manipulated through external 
condition control. For example, doxorubicin (DOX) has been a model drug for the study of drug 
delivery carrier because of its anti-cancer effect and strong fluorescence emission property which 
enables the localization and imaging functions.
77
 pH triggered release of DOX has been reported 
by using 1,2-cyclohexanedicarboxylic anhydride as a crosslinker. The conjugation efficiency of 
DOX silica is considerably high (>10% w/w) and the drug remains stable in neutral pH 7.4, but 
occurs rapid initial release under pH 5 and remains sustainable in days.
78
 
In controlled drug delivery, the function of SPION is not limited to providing magnetic 
property, but also concealing the load drug molecules in the porous structure as a cap and 
releasing upon external stimulus. A recent study has reported that SPION was first covalently 
conjugated on surface of MCM-41 silica after loading anticancer drug in mesopores, and then 
was detached from silica surface due to cleavage of covalent bonds under stimulus of magnetic 
field. It was discovered that there was neglectable amount of drug release without magnetic 
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stimulus, and the number of SPION detached, exposed silica surface and drug release rate can be 
precisely controlled by the time duration of magnetic field exposure.
79
 In another strategy, pH 
sensitive association/dissociation of SPION on silica was also exploited. Carboxybenzaldehyde 
functionalized SPIONs are able to closely bind to tri(aminomethyl)ethane (TAE) functionalized 
silica through non-covalent interaction in neutral pH as nanocap of the mesopores, and detach in 
acidic condition in endosome (pH 5).
80
 The hybridization between complementary ssDNA 
strands that conjugated on silica and SPION respectively has also been employed for thermal 
responsive release as the dissociation happens at temperature above 42°C, and the process is 
reversible. Coupling this response together with hyperthermia effect of SPION would achieve an 
optimized controllable release strategy.
81
 Other environmental responsive reactions that has been 
reported includes boronate esters linkage for pH response,
82
 disulfide linkage for redox 
response,
83
 
Thermal responsive polymers, for example, poly(ethyleneimine)-b-poly(N-
isopropylacrylamide) (PEI/NIPAM) that has dissociable bond at 35-40°C, are frequently 
employed as the modification of mesoporous silica. After drug molecules entering the porous 
structure, the polymer attached on silica surface acts as a temperature-responsive gatekeeper for 
loaded drug, and also retains other larger molecules such as therapeutic proteins within the 
polymer shell through electrostatic force or hydrogen bond to achieve a multi-drug carrier.
84
 
Other polymers, poly(N-isopropylacrylamide-co-methacrylic acid) (P(NIPAM-co-MAA))
85
 and 
P(NIPAM-co-NHMA) (NHMA: N-hydroxymethyl acrylamide)
46
  can be also introduced to 
achieve a thermo/pH dual-responsive release on silica shell. Besides polymer shell assembly, 
conjugation of functional organic molecule or inorganic nanocaps to guard the mesopores was 
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also studied to achieve triggered release promoted by various kind of stimulation, includes 
photo-responsive,
86,87
 redox responsive
86,88
, pH responsive
89-92
 and enzyme response.
93
 
 
1.4.2 Fluorescence imaging 
Fluorescence dye incorporated silica that coupled with conjugations targeting molecules such 
as folic acid, aptamer and antibody has been extensively reported for the purpose of bio-imaging. 
Dye molecule can be attached to silica surface by covalent binding to achieve water-dispersible, 
stable, and biocompatible product.
94,95
 However, due to the potential degradation of the binding 
and toxicity of the dye, an alternative approach became more popular: dye molecules can be 
easily doped into silica matrix by conjugating to silica precursor prior to the synthesis of silica 
nanoparticles. Due to the instant covalent bond formation between isothiocyanate and amine 
groups, Rhodamine B isothiocyanate (RITC) and fluorescein isothiocyanate (FITC) can first link 
to 3-aminopropyltriethoxysilane (APTES) as part of silica resource, and then introduced to the 
silica formation with other precursor such as TEOS. This doping technique ensures the stability 
of dye molecules and minimizes degradation and diffusion into physiological environment. In 
vitro cellular imaging generated by the doped dye helps to track and understand the cellular 
uptake of the nanoparticles, including intracellular location, concentration and accumulation 
through time.
44,53,96,97
 
As another fluorescence resource, semiconductive nanocrystals quantum dots possess unique 
advantages such as single excitation, narrow and tunable emission spectrum, strong and stable 
fluorescence intensity.
98
 And quantum dots integrated silica nanoparticles through different 
pathways such as surface covalent linkage
99
 and enclosed as composite,
100-102
 has been widely 
applied for both in vitro and in vivo fluorescence imaging.
103
 In addition, the combination of 
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quantum dots and silica can also be accomplished by using the spontaneous assembly between a 
positively charged polymer such as polyelectrolyte (PAH) and negatively charged fluorescent 
quantum dots (QDs) to form a composite shell onto silica surface.
104
 
Besides organic dye and quantum dots, lanthanide ion compounds also have unique 
luminescence properties, such as sharp emission lines, long lifetimes, good photostability, and 
effective elimination of short-lived scattering light and background noises.
105-107
 It was 
demonstrated that by conjugating the organic chromophore, chelation agent and silane precursor 
together as part of the resource and woven into silica nanoparticle during synthesis, terbium 
(Tb
3+
) can be successfully dope into silica network with good stability.
105
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Chapter II: Magnetic Porous Hollow Silica Nanostructures from CaCO3 
Template for Drug Delivery application 
 
2.1 Introduction 
During the recent decade, magnetic nanoparticles (MPs) have been widely studied for its 
significant potential in the biomedical field. They have been demonstrated as a promising 
candidate for applications such as Magnetic Resonance Imaging (MRI) contrast enhancement, 
targeted drug delivery, hyperthermia cancer treatment and bio-separation due to the 
characteristics of high saturation magnetization, superparamagnetism, high magnetic 
susceptibility and low toxicity.
1-4
 However, pure magnetic nanoparticle has various practical 
limitations for easily formed aggregation and being decomposed in a biological environment. 
Due to this reason, great effort has been focused on concealing the MPs into bio-compatible, low 
toxic materials for stabilization and protection
5-7
 by forming either core-shell structure or 
composite integration. The most commonly studied protective materials include organic 
molecules (oleic acid
8
, dopamine
9
, amino acid
10
), polymers (polyethylene glycol
11
, starch
12
, 
chitosan
13
 and polystyrene
14
) and inorganic compounds (TiO2
15
, SiO2
16
). Among all these 
materials, mesoporous silica is one of the most popular structuring materials because of the 
various precursors, low cost, and easily designable nature. Its high and well-documented 
biocompatibility is good for practical applications of magnetic nanoparticles in magnetically 
guided drug delivery and tumor targeting. Another outstanding advantage of mesoporous silica is 
the adjustable porous structure, with increased surface area and pore volume, which enables 
higher drug loading efficiency through surface absorbance and diffusion. 
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Furthermore, comparing to conventional porous silica material, hollow mesoporous silica 
nanostructures attracted more attention in the study of drug delivery carriers. The addition of 
accessible inner surface area through mesoporous channels can significantly increase the specific 
surface area and pore volume of the nanostructure; therefore, provide much higher storage 
capacity for drug molecules through massive diffusion or electrostatic absorption.
17-19
 This 
enhanced loading efficiency makes it a preferred host material for sustained and controlled 
release of a variety of chemical compounds.
20-23
  
Proper integration of mesoporous silica with magnetic nanoparticles could generate a new 
class of drug carrier for targeted delivery and controlled release. The magnetic hollow silica 
nanospheres, with a character of superparamagnetism, are considered to be the proper carriers for 
drug delivery. In this chapter, Fe3O4/CaCO3 composite particles were prepared by rotating 
packed bed (RPB) reactor first, and then employed as templates to fabricate hollow structure and 
the magnetic nanoparticles remains in hollow core after the removal of CaCO3. 
Hexadecyltrimethylammonium bromide (CTAB) and octane surfactants were used as second 
templates to direct the mesoporous structures in the silica shells to eventually achieve magnetic 
porous hollow silica nanospheres (MPHSN). To investigate the nanomedicine applications, the 
model drug ibuprofen with poor water solubility was loaded into the MPHSNs to study the drug 
loading capability and releasing performance. The toxicity of MPHSN was also investigated, and 
the result showed good bio-compatibility. 
On the other hand, silica nanotubes are another novel nanostructure that can be potentially 
used for carrying more drugs. Different from the nanospheres exposed only exterior surface, 
nanotubes with open ends offer both the inside and outside surface to interact with drug 
molecules, which largely increases surface/volume ratio and improves drug loading capacity. In 
23 
 
this chapter, the synthesis of magnetic porous hollow silica nanotubes (MPHSNT) using double 
templates method is also established using similar method. The resulted product possesses a 
large surface area with well-defined mesopores, good superparamagnetism property, low toxicity, 
and a slow release of ibuprofen was observed. 
 
2.2 Experimental 
2.2.1 Material and chemicals. Octane (98%), phosphate buffer saline (PBS, 10x stock solution), 
tetraethoxysilane (TEOS, 99.9%), hexadecyltrimethylammonium bromide (CTAB, 99%), 
phosphate buffer saline (PBS, 10x stock solution) were purchase from Sigma-Aldrich. Absolute 
ethanol was purchased from AAPer Alcohol and Chemical Co. and used as received. Ammonium 
hydroxide solution (28 wt%) and acetic acid (glacial) were purchased from J.T. Baker. Hexane 
(mixed isomers, 60+% n-hexane) was purchased from Alfa Aesar. Ibuprofen (USP grade) was 
purchased from MP Biomedical. Snakeskin pleated dialysis tubing (7,000 MWCO) was 
purchased from Thermo Scientific. 
 
2.2.2 Synthesis of CaCO3 sacrificial templates. The CaCO3/Fe3O4 composite nanoparticle was 
prepared by a high gravity reactive precipitation method using rotating packed bed (RPB) 
reactor.
24
 Briefly, 3500 ml of 5.4wt% Ca(OH)2 suspension was added to the reactor with a 
rotating speed of 750 r/min and circulated at 400 l/h at room temperature.
20,25,26
 After 10 min, 75 
ml of a methanolic dispersion of  Fe3O4 nanoparticles, which was prepared by a method based on 
the hydrolysis of chelate metal alkoxide complexes at elevated temperatures in solutions of 
diethylene glycol
27
 (15  mg/ml),  was  added  to the  system,  and  then  CO2 gas  was  introduced  
at  a  rate  of  100 l/h. When the pH value of the suspension reached 7.4, the CO2 gas was 
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stopped to end the reaction.  The obtained suspension was filtrated and dried at 70°C in vacuum 
for 6 h. CaCO3 nanoneedles were fabricated through a similar procedure without the addition of 
Fe3O4 nanoparticles. 
 
2.2.3 Synthesis of Magnetic Porous Hollow Silica Nanospheres (MPHSN). In a 250 ml three-
neck flask, 3.0 g of as-prepared Fe3O4/CaCO3 composite nanoparticles was dispersed 
ultrasonically into a mixture of 80 ml ethanol and 20 ml distilled water for 30 min and then 
stirred for 30 min. Next 0.74 g of CTAB was added to the above suspension and the obtained 
mixture was dispersed ultrasonically for another 20 min
28-30
 then stirred for 30 min using a 
mechanical stirrer. After that, 3.7 ml TEOS was added into the reaction mixture, dropwise, 
followed by adding the appropriate amount of ammonia (30%) to reach the pH value of 11. The 
system was stirred at 500 rpm for 2 h and aged for 6h at room temperature, then centrifuged. The 
precipitate was washed twice with distilled water and once with ethanol, then dried at 50ºC for 6 
h and calcined at 550ºC for 5 h in air.  Diluted acetic acid solution (HAc: H2O = 1:15 by volume) 
was used to remove the CaCO3 template by immersing the product in it for 5 h.  The product 
was ,afterwards, rinsed with distilled water and alcohol, and dried at 75°C for 18 h to yield the 
MPHSNPs. Mixed CTAB (0.74 g) and octane (3.30 ml) was also used as surfactant in a similar 
synthesis for the purpose of tuning the pore size of the silica shell. 
 
2.2.4 Synthesis of Magnetic Porous Hollow Silica Nanotubes (MPHSNT). The synthesis of 
MPHSNT is similar to the one of MPHSNS by using CaCO3 nanoneedles instead of 
Fe3O4/CaCO3 composite nanoparticles. Since the size of the as-prepared CaCO3 nanoneedles was 
extremely inhomogeneous and not qualified to be directly used in the synthesis, a size selection 
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process was performed to achieve more homogenous nanoneedles in advance. First, 20 g of 
original CaCO3 nanoneedles was ultrasonically dispersed in 200 ml ethanol for 2 h then 
introduced to a series of centrifuging with different rates and times. Then the size of the purified 
samples was checked with scanning electron microscope (SEM) in order to select the qualified 
template with acceptable size uniformity for the synthesis using the sol-gel method. First, 3 g 
size CaCO3 nanoneedles after size selection with dimensions of less than 1000 nm in length and 
200 nm in diameter were ultrasonically dispersed in a mixture of 80 ml ethanol and 20 ml 
distilled water in a three-neck flask for 25 min. Then 0.5 ml of a methanolic dispersion of Fe3O4 
nanoparticles (10.66 mg/ml) was added to the suspension above and dispersed in an ultrasonic 
bath for another 10 min. After that, 1 g of CTAB was applied to the mixture and ultrasonically 
dispersed for 20 min. Then the flask was settled under a mechanical stirrer and stirred at a rate of 
500 rpm. Appropriate amount of ammonia (30%) and 3.2 ml of TEOS was added into the 
reaction mixture within 10 min to reach the pH value 11. The system was continuously stirred at 
500 rpm for 6 h at room temperature, and then aged at room temperature for 4 h. The precipitate 
was washed twice with distilled water and once with ethanol, then dried at 50ºC for 6 h and 
calcined at 550ºC for 5 h in air.  Diluted acetic acid solution (HAc: H2O = 1:15 by volume) was 
used to remove the CaCO3 template by immersing the product in it for 5 h.  The product was 
afterwards rinsed with distilled water and alcohol, and dried at 75°C for 18 h to yield the 
MPHSNTs. Nanotubes without a mesoporous structure for the purpose of comparison was also 
prepared by skipping the surfactant CTAB during the sol-gel synthesis. 
 
2.2.5 Drug loading and releasing test of MPHSN. At room temperature, 75 mg of MPHSNS 
was mixed in 25 ml of ibuprofen solution with a concentration of 1.8 mg/ml in hexane and 
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stirred for 48 h, then collected through centrifuging, washed with hexane for one time and dried 
in air. The concentration of ibuprofen in the remaining hexane solution was obtained by a Varian 
Cary 500 UV-vis spectrophotometer after establishing a standard absorbance-concentration curve.  
After that, the drug loaded sample was dispersed in 50 ml of phosphate buffer saline (PBS) 
solution under slow magnetic stirring (300 rpm). At selected time points, 1 ml of the drug 
releasing dispersion was removed from the system, and 1 ml of fresh PBS was added back to the 
system immediately to maintain a constant volume. The 1 ml extracted dispersion was first 
centrifuged at 3500 rpm for 15 min, and then the upper clear solution was diluted with 4 ml of 
PBS and measured by UV-vis spectrophotometer.  
 
2.2.6 Drug loading and releasing test of MPHSNT. At room temperature, 25 mg of MPHSNT 
was mixed in 10 ml of ibuprofen solution with a concentration of 2.0 mg/ml in hexane and 
stirred for 48 h, then collected through centrifuging, washed with PBS solution for one time and 
dried in air. After that, the drug loaded sample was dispersed in 2 ml of PBS solution and loaded 
into a dialysis tube. Then the dialysis tube was soaked in a beaker carrying 10 ml PBS under 
gentle shaking using a vortex shaker. At selected time points, 2 ml of the solution outside dialysis 
tube was removed from each beaker, and 2 ml of fresh PBS was added back to the system 
immediately to maintain a constant volume. The 2 ml extracted solution was then diluted into 4 
ml with 1x PBS and measured by UV-vis spectrophotometer. After 48 hours of gentle release, the 
nanotubes were force to completely discharge the entire loaded drug by a three-hour sonication 
treatment. 2 ml of the final dispersion was centrifuged and the clear solution was diluted into 4 
ml with PBS and measured by spectrophotometer. The concentrations of the samples were 
obtained after establishing a standard absorbance-concentration curve. And the drug loading 
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efficiency of silica samples were calculated based on the released amount and concentration of 
final solution. 
 
2.2.7 Characterizations. A Carl Zeiss 1530 VP field emission scanning electron microscope 
(FESEM) and JEOL 2010 LaB6 transmission electron microscope (TEM) at an accelerating 
voltage of 200kv were used to examine the morphologies and sizes of the particles. Attached 
EDAX Genesis analyzer energy dispersive spectroscopy (EDS) was used to determine the 
composition of nanoparticles. ASAP2020 accelerated surface area and porosimetry system was 
applied to measure the surface area and pore size distribution of the magnetic porous hollow 
silica, denoted as BET analysis. The magnetic properties were measured on a Quantum Design 
MPMS-5S superconducting quantum interference device (SQUID) magnetometer.  
 
2.2.8 Toxicity test of MPHSN. Cell culture:  The rat brain cell line CRL-2199 (ATCC, Manassas, 
Virginia), was used for toxicity testing. Cells were maintained in the suggested medium 
consisting of Dulbecco’s Modified Eagle’s medium (with 4.5 g/L glucose, and 1 mM sodium 
pyruvate), 90%, and fetal bovine serum, 10%.  Cells were maintained in humidified 5% CO2 
incubators at 37° C. Exposure to nanoparticles:  CRL-2199 cells were plated onto 35 mm dishes 
at a density of 50,000 cell/ml.  Twenty-four hours after plating, the cells were exposed to 50 
µg/ml of porous silica nanoparticle or copper nanoparticle (Sigma-Aldrich, St. Louis, Missouri).  
Nanoparticles were prepared as a 20x solution in CRL-2199 growth medium and sonicated 
before addition to cells. Imaging and assessment of toxicity:  Cell growth or death was monitored 
in a pre-marked position of each 35 mm dish and digital images obtained at 40 X magnification 
using a Nikon Eclipse TE 2000-U model inverted microscope with Photometrics Coolsnap ES 
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camera and Metamorph acquisition software.  After acquisition, digital images were measured 
for cell growth coverage using Image Pro Plus image analysis software (Version 6.1, Media 
Cybernetics, Silver Spring, Maryland). 
 
2.2.9 Toxicity test of MPHSNT. Cell culture:  The rat brain cell line CRL-2020 (ATCC, 
Manassas, Virginia), was used for toxicity testing.  Cells were maintained in the suggested 
medium consisting of RPMI 1640 medium 90%, and fetal bovine serum, 10%.  Cells were 
maintained in humidified 5% CO2 incubators at 37° C. Exposure to nanoparticles:  CRL-2020 
cells were plated onto 12-well poly-lysine coated culture plates at a density of 30,000 cells/ml.  
72 hours after plating, cells were exposed to 50 µg/ml of fabricated porous silica nanotubes or 
copper nanoparticles (Sigma-Aldrich, St. Louis, Missouri) and placed back into 5% CO2 
incubators as above for 4.5 hours.  Nanotubes and nanoparticles were prepared as a 20x 
concentrated stock in Locke’s solution and sonicated before addition to cells. Cell staining:  After 
exposing cells to nanotubes or nanoparticles for 4.5 hours, cells were then loaded with 1 µM of 
calcein (Invitrogen) and 4 µg/ml of propidium iodide (Sigma-Aldrich) for 30 minutes in a CO2 
incubator, and then imaged by microscopy. Imaging and assessment of toxicity:  Cell growth or 
death was monitored in a pre-marked position of each well and digital images obtained at 200 X 
magnification using a Nikon Eclipse TE 2000-U model inverted microscope with Photometrics 
Coolsnap ES camera and Metamorph acquisition software using phase and epifluorescence 
microscopy for calcein and propidium iodide.          
 
2.3 Result and discussion 
29 
 
2.3.1 Preparation of Fe3O4/CaCO3 composite nanoparticle template. In the synthesis of 
Fe3O4/CaCO3 composite template, RPB (as shown in Scheme 2.1) was employed as a reactor in 
order to enhance the micromixing strength of the reactant so that the size, size distribution, and 
reaction rate of CaCO3 nanoparticles can be improved.
20
 Figure 2.1(a) is a TEM micrograph 
showing the successfully synthesized Fe3O4/CaCO3 composite nanoparticles. The diameters of 
CaCO3 are about 60-90 nm with magnetic nanoparticles (darker dots) embedded as composite 
structure. The nanoparticles are slightly aggregated because of the nature of nanoparticles and 
lack of stabilizing ligand in the synthesis. According to the EDS spectrum shown in Figure 2.1(b), 
the clear appearance of peaks representing C, O, Ca, and Fe besides Cu peak from TEM grid 
confirms that composite nanoparticles are indeed composed of CaCO3 and Fe3O4 compounds.  
 
Scheme 2.1 Rotating packed bed (RPB) reactor: (1) CO2 gas inlet; (2) rotator; (3) packing; (4) 
distributor; (5) casing and routeway of circulating water; (6) outlet of suspension of Ca(OH)2 and 
Fe3O4; (7) CO2 gas outlet; (8) inlet of suspension of Ca(OH)2 and Fe3O4.
24
 Reprinted with 
permission. Copyright 2007 American Chemical Society. 
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Figure 2.1 Fe3O4/CaCO3 magnetic composite nanoparticles. (a) Bright-field TEM micrograph. 
The Fe3O4 nanoparticles appear in darker dots embedded in the CaCO3 particles. (b) The EDS 
spectrum of the composite particles. 
 
 
Scheme 2.2 Synthesis of Magnetic Porous Hollow Silica Nanospheres (MPHSNP).  
 
2.3.2 Synthesis of Magnetic Porous Hollow Silica Nanospheres (MPHSNs) and BET analysis. 
The typical synthesis procedure of MPHSN is illustrated in Scheme 2.2. During the silica shell 
coating on Fe3O4/CaCO3 composite nanoparticle using sol-gel method, cation surfactant CTAB 
was first applied as a second template to direct the formation of the mesoporous structure. The 
cationic carbon chains of CTAB are able to blend with the anionic silicate TEOS molecules upon 
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contact to build hexagonal mesophase on the outside surface of the CaCO3 composite 
nanoparticle,
31
 and the amorphous silica shell is formed through the hydrolysis and condensation 
of TEOS after the addition of ammonia as a catalyst. After the calcination of CTAB and the 
removal of CaCO3, by using diluted acetic acid, the magnetic nanoparticles can be clearly 
observed inside the silica hollow cores, concealed by silica shell with the detailed hexagonal 
arranged porous structure as shown in Figure 2.2(a). The EDS analysis in Figure 2.2(b) shows no 
Ca peak, implying that CaCO3 was completely etched away after the reaction.  
 
 
Figure 2.2 TEM image (a) and EDS spectrum (b) of MPHSNs. The inset is a HREM image, 
showing pores on the hollow silica shell. 
 
After etching away CaCO3, hollow silica nanospheres containing magnetic nanoparticles 
were obtained.
24
 The surface area of the products was evaluated by nitrogen adsorption-
desorption isotherms as shown in Figure 2.3. The isotherm of the sample with only CTAB as 
well as the one with CTAB and octane possesses a higher position along the vertical axis, 
indicating a larger pore volume. Also, comparing the sharper inflection on the isotherm to the 
sample without any surfactant represents uniform pore size formation during capillary 
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condensation. The actual pore size distribution was achieved through calculation in BJH method 
and shown in Figure 2.4. According to position of the peak, the pore size of the MPHSNs 
modified with and CTAB and mixed CTAB and octane are 3.9 nm for and 3.7 nm, respectively, 
while the sample without any surfactant during preparation doesn’t present any distinguishable 
distribution peak, suggesting less pore size uniformity. This means that a surfactant induced 
mesoporous structure was successfully formed during the synthesis and were removed during the 
calcination and rinsing process. The summarized data regarding surface area and pore size is 
shown in Table 2.1.  
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Figure 2.3 Nitrogen absorption-desorption 
isotherms of MPHSNs. 
Figure 2.4 Pore size distribution for the MHSNs 
sample calculated using BJH method. 
 
Table 2.1 BET surface area and pore texture parameters of the MPHSNs. 
Surfactant 
Pore size 
diameter (nm) 
BET 
surface 
area (m
2
/g) 
Drug-load amount 
(%) 
none 1.5 91.9995 8.70% 
CTAB 3.9 334.4838 14.88% 
CTAB and octane 3.7 242.8824 14.21% 
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Scheme 2.3 Synthesis of Magnetic Porous Hollow Silica Nanotubes (MPHSNTs). 
 
2.3.3 Synthesis and morphology of MPHSNT and BET analysis. The synthesis procedure of the 
magnetic hollow silica nanotube (MPHSNT) is illustrated in Scheme 2.3. CaCO3 nanoneedles 
serve as the first template to build the nanotube structure. However, as shown in the SEM images 
in Figure 2.5(a), as-prepared CaCO3 nanoneedles direct from RPB present very wide distribution 
in size. The length of the nanoneedles varies from about 200 nm to several microns, and the 
diameter is in the range between tens of nanometer and micron scale. Template with 
inhomogeneity like this is not suitable for the fabrication of a nanotube drug carrier for multiple 
reasons: 1) the large sized template makes it hard to penetrate into the cell to deliver the drug; 2) 
the small sized template may cause massive aggregation of the nanotubes due to the nature of 
nanomaterials. Therefore, a size selection process was conducted to remove the extra large and 
small nanoneedles by centrifuging the CaCO3 nanoneedles/ethanol dispersion at different rates 
and times. As the SEM image shown in Figure 2.5(b), the CaCO3 nanoneedle template after sized 
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selection has a relative uniform diameter of 200 nm and length below 1.5 µm, which is qualified 
for the nanotube synthesis. 
 
Figure 2.5 SEM image of CaCO3 nanoneedle template (a) before and (b) after the size selection 
process. 
 
 
Figure 2.6 SEM image of MPHSNTs showing general morphology. 
 
CaCO3 nanoneedles after size separation was ultrasonically dispersed and mixed with Fe3O4 
nanoparticles. Then cation surfactant CTAB was applied to direct the formation of mesoporous 
structure, followed by the hydrolysis and condensation of TEOS under the presence of ammonia 
hydroxide to form the silica shell. After the removal of both templates through calcination and 
acidic etching, MPHSNT can be achieved. As shown in the SEM image in Figure 2.6 which 
provides morphology information of the magnetic porous hollow silica nanotube (MPHSNT), the 
diameter of the nanotubes is below 200 nm and the length is within 1000 nm as pre-determined 
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by the CaCO3 template. Another noticeable point is that most of the nanotubes were broken in 
the middle with opened ends exposed. This will increase the mesoporous surface area for drug 
loading which is preferred for drug delivery.  
 
Figure 2.7 (a) TEM image of a MPHSNT, showing the middle region the nanotube. The size of 
the darker contrast magnetite nanoparticles is about 10 nm. (b) The EDS spectrum of MPHSNT. 
 
Table 2.2 BET surface area and pore texture parameters of the MPHSNTs. 
Surfactant  
Pore size 
diameter (nm)  
BET 
surface 
area (m
2
/g)  
Drug-load amount 
(%, w/w)  
none 1.5 43.7807 7.31 
CTAB 2.5 118.6742 13.87 
 
Figure 2.7(a) is a TEM image showing the middle region of a single MPHSNT. The thickness 
of silica shell is about 20 nm and the magnetite nanoparticles, with diameters about 10 nm, 
appear as darker dots. It can be clearly seen that from the edge of the shells the magnetite 
nanoparticles (denoted by arrows) are successfully embedded in the silica shell. Figure 2.7(b) is 
the EDS analysis, showing the Si, Fe, and O besides the C and Cu peaks from the sample grid. 
The presence of the Fe peak also confirms the existence of Fe3O4 nanoparticles. In addition, the 
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absence of Ca peak indicates that the CaCO3 template was completely etched away by the 
diluted acetic acid, leaving the hollow interior. 
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Figure 2.8 (a) Nitrogen absorption-desorption isotherms of MPHSNTs. (b) Pore size distribution 
for the MPHSNTs sample calculated using BJH method. 
 
During the synthesis of MPHSNT, the cationic surfactant CTAB was introduced as a second 
template to direct porous structure formation within the silica shell. Information regarding 
surface areas and pore volume was obtained by measuring N2 adsorption-desorption isotherms 
and pore size distribution was calculated by BJH method. From the isotherms in Figure 2.8(a), it 
can be clearly seen that the nanotube with surfactant has a much sharper inflection than the one 
without surfactant during preparation, indicating a more homogeneous mesoporous structure. In 
Figure 2.8(b), CTAB modified nanotubes represent a quite uniform pore size distribution around 
2.5 nm compared with the samples without surfactant modification showing no obvious peak. 
These mesopores significantly increase the surface area of the nanotube as summarized in Table 
2.2, and also behave as nano-channels run through the silica shell, providing a pathway for drug 
molecule adsorption on both the inside and outside surface for more efficient delivery.  
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2.3.4 Magnetic measurements. The magnetic properties of the MPHSN and MPHSNT were 
measured by SQUID. Zero-field-cooled (ZFC) and field-cooled (FC) magnetization data 
measured in the temperature range of 5-300 K are shown in Figure 2.9(a) and Figure 2.10(a). In 
the ZFC measurement, the initial field was set to zero when cooling the sample from 300 K to 5 
K. A field of 100 Oe was applied and the magnetization was measured as the sample was heated 
from 5 to 300 K. In FC measurement, a field of 100 Oe was applied as the sample was cooled 
from 300 K to 5 K and the magnetization was measured as the sample was heated from 5 to 300 
K, in the field of 100 Oe. The ZFC curves show a maximum at 98.5 K and 83.7 K for MPHSN 
and MPHSNT, respectively, which are the blocking temperatures (TB) of the magnetic 
nanoparticles in the samples. Such behavior is the characteristic of superparamagnetism and is 
due to the progressive blocking of the magnetic moment of the nanoparticles when decreasing 
the temperature.  
Both the nanospheres and nanotubes exhibit superparamagnetism and ferromagnetism above 
and below the blocking temperature, respectively. To ensure these features, the field-dependent 
hysteresis loops of the MPHSNs were measured at 5 K (<TB) and 300 K (>TB), as shown in 
Figure 2.9(b) and Figure 2.10(b).  For MPHSN, the hysteresis loop at 5 K shows a saturation 
magnetization of 1.4 emu/g (at the field of 10000 Oe) and a coercivity of 173 Oe, which 
confirms that the MPHSNs are ferromagnetic below the blocking temperature. The MPHSNTs 
present the same ferromagnetic property with a saturation magnetization of 1.35 emu/g and a 
coercivity of 152 Oe at 5 K. The absence of coercivity in the hysteresis loop at 300 K for both 
samples indicates a superparamagnetism behavior. The MPHSNs and MPHSNTs possess 
superparamagnetic properties at room temperature, which means they can be attracted by a 
magnetic field but retain no residual magnetism once the magnetic field is removed. 
θ 
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Figure 2.9 Magnetic properties of the MHSNs: (a) temperature dependence of magnetization at 
ZFC and FC conditions; (b) hysteresis loops of the MHSNs at 5 and 300 K. 
 
 
Figure 2.10 Magnetic properties of the MPHSNTs: (a) temperature dependence of magnetization 
at ZFC and FC conditions; (b) hysteresis loops of the MHSNs at 5 and 300 K. 
 
2.3.5 Drug loading and releasing. To explore the drug carrying capacity of MPHSNs, ibuprofen, 
a typical anti-inflammatory drug with poor water solubility, was introduced into the pores of the 
MPHSNs by immersion in stock solution. The uptake amount of ibuprofen, assessed by UV 
analysis, was 8.7%, 14.88% and 14.21% for the MPHSNs with pore size of 1.5 nm, 3.9 nm and 
3.7 nm (as shown in Table 2.1), respectively, which indicates that the loaded amount of ibuprofen 
varies with the change of the pore size and surface area. In-vitro release behavior was also 
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investigated by UV-Vis absorbance measurements, as shown in Figure 2.11. It was observed that 
about 42% and 15% ibuprofen released from the MPHSNs with pore size of 3.9 nm (CTAB) and 
3.7 nm (CTAB and octane) during the first half an hour, respectively, and 50% and 42% were 
released after 24 h respectively. It can be explained that a noticeable amount of drugs entered the 
mesopores of the hollow structure after modification by the surfactants, resulting in the later 
sustained release. However, more than 80% of ibuprofen for the MPHSNs without surfactant 
directed mesoporous structure was released within the first 0.5 h, which indicates that most of 
ibuprofen was only loaded on the surface of the silica hollow spheres and caused fast initial 
release.  
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Figure 2.11 In vitro drug release of ibuprofen from the MPHSNs showing sustained release. 
 
The drug loading and releasing study for MPHSNTs was also carried out using ibuprofen. 
The drug loading efficiency of MPHSNT and non-porous nanotube that was prepared as control 
was 13.87% and 7.31% (w/w) respectively, which is equally comparable to values of 
nanospheres. It can be explained as the exposure of both the inside and outside surface in 
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nanotubes, which results in an increased surface/volume ratio. However, while combined with 
reduced surface/weight ratio due to larger dimensions and thicker silica walls compared to 
nanospheres, no significant increase of drug loading efficiency was observed. During the 
investigation of drug release, a dialysis technique was employed to enclose the drug loaded 
nanotube instead of simple stirring in the release media in order to minimize the external  
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Figure 2.12 In vitro drug release of ibuprofen for MPHSNTs (20 mg) with and without CTAB 
directed mesoporous structure. The amount of loaded drug was calculated as 1.462 mg for non-
surfactant sample and 2.774 mg for CTAB modified sample. 
 
influence from mechanical disturbance. Unlike mesoporous hollow nanosphere which has an 
extinguishable sustained release behavior compared with non-porous spheres, both of the 
nanotube samples, with and without mesopores, exhibit release behavior of approximate 70% of 
the loaded drug during the first hour and 85% after 5 hours. It is then subject to slow release of 
remained amount of drugs, as shown in Figure 2.12. The lack of obvious controlled release 
during initial period can be explained as the broken-in-half nanotubes are serving more like 
double surfaced vessels rather then hollow capsules, in which the drug molecules adsorbed on 
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both interior and exterior surfaces can be released at the same time, which resulted in relatively 
fast initial release. This performance may be more suitable for the treatment of acute infection 
which requires high drug concentrations to begin with. 
 
Figure 2.13 CRL-2199 cell toxicity:  phase microscopy.  Cells were treated with control media 
(A+B), or with 50 µg/ml of copper nanoparticles (C+D) or MPHSN nanoparticles (E+F).  Panels 
A, C, and E show cultures 5 minutes after treatment and panels B, D, and F at 20 hours after 
treatment.  The large black dot in each figure is an orientation marker to ensure that the same 
area or cells is monitored over time.  Scale bar indicated. 
 
2.3.6 Toxicity studies. Biocompatibility/toxicity of MPHSNs was tested using the CRL-2199 
brain cell line. By comparing the culture treated by 50 µg/ml MPHSN (Figures 2.13 E+F) to the 
one with only growth media (Figures 2.13 A+B) as blank control at the beginning and 20 hours 
after applying the nanomaterials, the cells are not showing any obvious sign of death or inactivity, 
but continue to regular growth and proliferation, indicating low toxicity of as-prepared magnetic 
silica particle. However, in contrast to the cells cultivated with copper nanoparticles at the same 
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concentration (Figures 2.13 C+D) which is anticipated as toxic material, the cells presented low 
viability and no proliferation after 20 hours of incubation. This result indicates that the MPHSN 
may have potential bio-medical application due to the characteristic of bio-compatibility. 
 
Figure 2.14 CRL 2020 Brain tumor cells grown at a density of 30,000 cells per ml were treated 
with 50 μg/ml of silica nanotubes (D-F) or copper nanoparticles (G-I), or with Locke’s solution 
as a control (A-C) for 4.5 hours.  Phase microscopy pictures, or same areas stained with calcein 
or propidium iodide are indicated.  Original microscope magnification= 200 x.   
 
To assess the biocompatibility or potential toxicity of the synthesized silica nanotubes, we 
exposed the brain cell line CRL 2020 to 50 µg/ml of the fabricated nanotubes and 50 µg/ml of 
copper nanoparticles respectively for 4.5 hours under normal growth conditions in a 5% CO2 
incubator. Cell cultivated as the blank control were treated with only physiological Locke’s 
solution.
32
  Staining of cells with the vital dye calcein indicated that control cells (Figure 2.14B) 
and cells treated with nanotubes (Figure 2.14E) were almost completely viable by comparing 
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with blank control, indicating no toxic effect from the nanotubes. In contrast, treatment of cells 
with 50 µg/ml of copper nanoparticles caused almost complete loss of calcein staining (Figure 
2.14H), and the appearance of significant propidium iodide (PI) staining (Figure 2.14I), an 
indication of cell death.  Control cells and cells treated with nanotubes showed no significant PI 
staining (Figure 2.14C and F, respectively), demonstrating, by a second indicator, that nanotubes 
under these conditions are not toxic. As a third marker, no major morphological changes 
appeared to be occurring due to nanotube exposure under these conditions:  cells exposed to 
nanotubes (Figure 2.14D) appear similar to control cells under phase microscopy (Figure 2.14A), 
whereas cells exposed to copper nanoparticles show obvious membrane blebbing and cell rupture 
indicative of cell injury (Figure 2.14G). 
 
2.4 Conclusion 
In this chapter, magnetic porous hollow silica nanospheres as targeting drug carriers were 
successfully synthesized using CaCO3/Fe3O4 composite nanoparticles as the first template, and 
cationic surfactants as the second template in a sol-gel system. The results show that the pore 
size of the MPHSNs can be tuned by adjusting the surfactants in the system. No CaCO3 and 
surfactant were left after calcination and weak acid etching. SQUID measurements show that the 
MPHSNs still maintain the superparamagnetic behavior after the calcination. In addition, in vitro 
release study of ibuprofen shows that MPHSNs can significantly sustain the drug release, and 
toxicity test suggests good biocompatibility, which indicates their strong potential applications in 
the biomedical field. Also, magnetic porous hollow silica nanotubes (MPHSNTs) were also 
successfully prepared by using CaCO3 nanoneedle as the sacrificial template for the hollow 
structure. Most of the obtained nanotubes were broken in the middle and both the interior and 
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exterior surface of the tube can be exposed to interact with drug molecules, which largely 
increase the drug loading efficiency. A slow release behavior of ibuprofen was observed 
compared to the sample without mesoporous feature, and superparamagnetism property from the 
Fe3O4 nanoparticles was preserved. Both of the nanospheres and nanotubes showed low toxicity 
in human cells, indicating great potential as qualified carriers for targeted drug delivery. 
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Chapter III: Magnetic porous hollow silica nanospheres (MPHSNs) templated 
from polystyrene beads  
 
3.1 Introduction 
Superparamagnetic iron oxide nanoparticles (SPIONs) possess the unique feature of zero 
coercivity which allows the particles to move toward and stay at a desired area under the 
existence of an external magnetic field and leaves no residual magnetization upon removal of the 
magnetic field.
1
 This characteristic is significantly beneficial for magnetic targeted drug delivery 
which is in high demand for the treatment of infections and tumors nowadays. In recent years, 
numerous efforts have been made on the efficient and convenient integration of SPIONs on 
mesoporous silica to combine the benefits of superparamagnetism, large surface area and good 
bio-compatibility as the platform for various bio-medicine applications such as targeted drug 
delivery, multimodal imaging, hyperthermia treatment and bio-separation.
2,3
 So far, many 
strategies have been developed for this purpose, including SPION/silica core-shell structures,
4-6
  
rattle type structures,
7-9
 as well as embedded composite structures in which the SPIONs are 
grown inside silica mesoporous framework.
10-12
  One of the most direct approaches is covalently 
conjugating SPIONs on a silica surface through linkage reactions such as amine-carboxyl,
13
 
amine-thiol
14
 and amine-bromine.
15,16
 Being as straight forward as it is, this method invites 
complexities of relatively low crosslinking efficiency, complicated preparations of both silica 
and SPION, and sophisticated ligand exchange processes of magnetic particles, which makes it 
time consuming and less scalable. Therefore, a more facile approach with higher efficiency of 
the decoration of SPIONs on silica with an additional advantage of availability for further 
functionalization is highly preferred. 
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In this chapter, two different pathways were used to synthesize magnetic porous hollow silica 
nanospheres (MPHSNs) for the application of drug delivery. In the first approach, PS 
nanoparticles with carboxylic group functionality were prepared by introducing acrylic acid as a 
comonomer, and then attached with Fe3O4 nanoparticles through either covalent bindings or in-
situ growth, followed by silica coating and PS template removal to achieve the hollow structure. 
In the second approach, mesoporous hollow silica nanospheres were first synthesized basing on 
the PS nanoparticle templating, then the in-situ growth of Fe3O4 nanoparticles was conducted in 
a mixed polyamine-polyalcohol media to obtain magnetic decorated hollow sphere with amine 
functionality. The resulted product from the latter procedure reserved the mesoporous structure 
from the original silica nanospheres and exhibited strong superparamagnetism properties at room 
temperature. And the reactive amine groups were available for further modification and 
functionalization such as fluorescence conjugation. 
 
3.2 Experimental 
3.2.1 Material and chemicals. Styrene (99.0%), 2,2’-Azobis(2-methylpropionamidine) 
dihydrochloride (V-50, 97.0%), polyvinylpyrrolidone  (PVP40, 99.5%), 
hexadecyltrimethylammonium  bromide (CTAB,  99.0%),  [2-(acryloyloxy)ethyl]  
trimethylammonium  chloride  (AETAC,  80  wt  %  in  water),  tetraethoxysilane (TEOS, 
99.9%), potassium persulfate (K2S2O8, 99%), sodium dodecyl sulfate (SDS, 99%), sodium 
bicarbonate (NaHCO3, 99.5%), acrylic acid (99%), allylamine (99%), divinyl benzene (80%, 
mixture of isomers), (3-Aminopropyl)triethoxysilane (APTES, 98%), diethylene glycol (DEG, 
99%), triethylene glycol (TREG, 99%), tetraethylene glycol (TEG, 99%), triethylenetetramine 
(TETA, 97%), tetraethylenepentamine (TEPA, technical grade), iron(III) acetylacetonate 
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(Fe(acac)3, 97%), iron(II) chloride tetrahydrate (FeCl2•4 2O, 99%), Iron(III) chloride 
hexahydrate (FeCl3•6 2O, 99%), sodium hydroxide (NaOH, 99%), N-(3-Dimethylaminopropyl)-
N′-ethylcarbodiimide hydrochloride (EDC, 99%), N-Hydroxysuccinimide (NHS, 98%)  were 
purchased from Sigma-Aldrich. Absolute ethanol was purchased from AAPer Alcohol and 
Chemical Co. and used as received. Ammonium hydroxide solution (28 wt%) was purchased 
from J.T. Baker. Amicon Ultra centrifuge filter (regenerate cellulose 30K MWCO) was 
purchased from Millipore for spin dialysis. Water soluble CdSe/ZnS core/shell quantum dots 
with 595 nm emission peak and carboxyl functionality were purchase from Ocean Nanotech. 
 
3.2.2 Synthesis of polystyrene nanoparticles. The synthesis procedures described below are 
based on published work
17-22
 with modification using our limited apparatus set-up: round bottom 
three-neck flask, hotplate, sandbath and condenser connected with cooling water.  
PVP method: In a 250 ml round bottom three-neck flask, 0.224 g of PVP40 was dissolved in 
158 ml of distilled water, and kept stirring at 1200 rpm on a hotplate for 20 min. Then 17.0 
ml/15.5 g of styrene was added in the solution and the emulsion was purged with nitrogen and 
stirred for another 30 min. After heated to 70°C with a sand bath, 2.4 ml of V-50 (10 wt % in 
water) was added to induce the polymerization and the reaction mixture was refluxed at 70 °C 
for 24 hours under constant nitrogen flow. 
Divinyl benzene method: In a 250 ml round bottom flask, 3.0 ml of styrene and 0.030 ml of 
divinyl benzene was injected into 100 ml of H2O under vigorous stirring and nitrogen purge. An 
AALABORG GFM17 mass flow meter was used to monitor the flow rate of nitrogen. After 
heated to 70°C, 6.0 ml of 37 mM K2S2O8 aqueous solution was injected to initiate the 
polymerization. At the same time, various amount of acrylic acid was also added to provide 
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functional carboxyl group for the purpose of further surface modification. The reaction was kept 
under reflux and nitrogen for 24 h and the mixture was introduced to reduced pressure filtration 
to remove the large agglomeration that caused by insufficient stirring. 
 
3.2.3 Synthesis of amine-ended Fe3O4 nanoparticles, linkage to carboxyl-ended PS beads and 
formation of magnetic porous hollow silica nanospheres (MPHSNs). Fe3O4 nanoparticles with 
reactive amine surface functionality were first prepared based on a published method with 
modification.
23
 In a 50 ml three-neck flask, 0.177 g (0.5 mmol) of Fe(acac)3 was mixed with 10 g 
of TETA via magnetic stirring under a flow of nitrogen, and the mixture was first heated to 
200°C for 30 min, then eventually heated to 260°C for another 1.5 h. The obtained Fe3O4 
nanoparticles with water solubility were magnetically collected, washed 5 times with acetone 
and then redispersed in 10 ml of H2O.  
Through spin dialysis, 10 mg of PS beads with carboxyl functional group from the divinyl 
benzene method was collected and redispersed in 2 ml of H2O. Then 100 mg of zero-length 
crosslinker EDC and 10 mg of NHS were dissolved in the PS beads dispersion to have the 
carboxyl group activated for 15 min, followed by mixing with 0.5 ml of Fe3O4 nanoparticle 
aqueous solution described above and 7.5 ml of H2O. The reaction lasted 4 h before washed with 
ethanol for 5 times and redispersed in 10 ml of ethanol. 
At last, 2 ml of the magnetic nanoparticles linked PS beads obtained above was diluted with 
10 ml of ethanol and dispersed under ultrasonic for 30 min, followed by adding 0.020 g of PVP 
and moved to magnetic stirring at 1200 rpm at room temperature. Then 0.3 ml of TEOS and 1.0 
ml of APTES was applied as precursor of silica and the reaction mixture was stirred for 12 h. 
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3.2.4 In-situ growth of Fe3O4 nanoparticles on PS beads. The synthesis and in-situ attach of 
Fe3O4 nanoparticles to PS beads was carried out through a polyol mediate synthesis method
24
 
with modification. In a typical procedure, 0.16 g of NaOH (40 mmol) was first dissolved in 10 g 
of DEG by stirring overnight. Then 15 mg of PS beads, which was separated from original 
reaction solution by spin dialysis, as well as 25 mg of FeCl2•4 2O (0.125 mmol) and 67.5 mg of 
FeCl3•6 2O (0.25 mmol) was dispersed in 20 g of DEG and stirred for 1 h. Under a flow of 
nitrogen, the two solutions were then mixed together and stirred for another 3 h, followed by 
heating to 220°C via controlled ramp (room temperature (RT) to 150°C at 3°C/min, then heat to 
220°C at 1°C/min). After naturally cooled down to room RT, the sample was collected through 
magnet and washed 5 times in acetone, then dispersed in ethanol.  
 
3.2.5 Synthesis of mesoporous hollow silica nanospheres (MHSN). In a typical experiment, 5 
mg of PS beads was first separated from original reaction solution by spin dialysis, and then 
ultrasonically dispersed in a mixture of 8 ml ethanol and 2 ml of H2O in a 20 ml vial. 
Appropriate amount of CTAB which serves as surfactant was added to direct the formation of 
porous structure during 1 h of magnetic stirring. Then the solution was heated to 50°C and 
certain amount of TEOS was dropwisely applied, followed by addition of concentrated 
ammonium hydroxide to initiate the hydrolysis of TEOS. The reaction was kept at elevated 
temperature for 24 hours and the product was washed with ethanol and dried in air. At last, the 
dried product was calcined at 600 °C for 6 h to remove the PS and CTAB templates, and the 
mesoporous hollow silica nanospheres was achieved. Synthesis using H2O only, ethanol only, 
different H2O/ethanol ratios, and 10 times large scale were also studied.  
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3.2.6 In situ growth of Fe3O4 nanoparticles on mesoporous hollow silica nanospheres. Based 
on a typical thermal decomposition method, Fe3O4 nanoparticles were synthesized and attached 
to the surface of MHSNs through a one-pot procedure.
23,25,26
 Briefly, 40 mg of MHSN was 
dispersed in 2 ml of water for 20 min in ultrasonic bath, then mixed with x g of TEG, y g of 
TETA or TEPA, (x+y=10) and 0.177 g (0.5 mmol) of Fe(acac)3 in a 50 ml three-neck flask 
connected with nitrogen inlet, condenser and temperature controller. Under a flow of nitrogen 
and magnetic stirring, the reaction mixture was first heated to 120-150°C for about 30 min to 
remove the water through evaporation. The temperature was then raised to 220°C for 2 h during 
which the Fe(acac)3 started to decomposes. Eventually, the mixture was heat to 300°C for various 
amount of time and the product was magnetically collected, washed 5 times with acetone and re-
dispersed in ethanol. 
 
3.2.7 Fluorescence conjugation on in situ Fe3O4 decorated mesoporous silica nanospheres. 
First, 5 mg of as-prepared magnetic silica nanospheres was sonicately dispersed in 2 ml of PBS. 
Meanwhile, 5 µl of water soluble CdSe/ZnS core/shell quantum dots (8 nM) with 600 nm 
emission peak and carboxyl functionality was activated with 20 mg EDC in 2 ml of PBS for 15 
min, then react with the silica dispersion in a sonication bath for 3 h. The product was then 
magnetically separated and washed with de-ionized water for multiple times (>5) until the upper 
clear solution not showing fluorescence under UV lamp. Fluorescence imaging was performed 
using a digital fluorescence imaging microscopy system that consisted of an inverted 
fluorescence microscope (Olympus IX70) equipped with a 100-W mercury lamp as a light source. 
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3.2.8 Characterizations. A Carl Zeiss 1530 VP field emission scanning electron microscope 
(FESEM) and JEOL 2010 LaB6 transmission electron microscope (TEM) at an accelerating 
voltage of 200kv was used to examine the morphologies and sizes of the particles. Attached 
EDAX Genesis analyzer energy dispersive spectroscopy (EDS) was used to determine the 
composition of nanoparticles. ASAP2010 Surface Area Analyzer was applied to measure the 
pore size distribution of the magnetic porous hollow silica. The magnetic properties were 
measured with a Quantum Design MPMS-5S SQUID magnetometer. X-ray powder diffraction 
(X D) data was obtained on a  hilips X’ ert-MPD diffractometer equipped with a graphite 
monochromator and Cu Kα (1.5418 Å) radiation. Surface composition of the samples was 
examined by Thermo Nicolet Nexus 670 FT-IR machine. 
 
3.3 Result and discussion: 
In order to achieve MPHSN using polystyrene nanoparticles as a sacrificial template, we 
proposed a synthesis route as shown in Scheme 3.1. PS particles with carboxyl modification are 
first synthesized then linked with amine-functionalized Fe3O4 nanoparticles under EDC catalysis. 
After that, surfactant CTAB guided silica coating can be applied to achieve mesoporous shells 
with Fe3O4 embedded in it, and both the templates are removed through calcination to obtain the 
hollow construction. 
 
Scheme 3.1 Synthesis approach for magnetic porous hollow silica nanospheres using PS beads as 
template. 
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Figure 3.1 TEM images of PS nanoparticles synthesized with (a) 13.8 mM, (b) 34.4 mM, (c) 41.4 
mM, (d) 68.8 mM of acrylic acid. 
 
3.3.1 PS nanoparticle synthesis with acrylic acid as comonomer. In favor of having functional 
carboxyl groups on the surface of PS nanoparticles for the purpose of improving dispersity and 
further modification, a series of syntheses with acrylic acid as the comonomer were also 
conducted using an emulsifier-free method. Generally, this system consists of styrene as the 
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monomer, potassium persulfate (K2S2O8) as the polymerization initiator, and divinyl benzene as 
the crosslinker.
18
 In addition, water soluble comonomers such as acrylic acid have been used for 
controlling the size distribution and surface functionality of the particles.
27-29
 Also, the surface 
charge that was introduced by the use of the comonomer would protect the particles from 
aggregation and increase the mono-dispersity.
18
 Herein, different concentrations of acrylic acid 
were applied in the synthesis.  
TEM images in Figure 3.1 represent the morphology of the PS nanoparticles obtained in 
different acrylic acid concentrations, from 13.8 to 68.8 mM. It can be clearly seen that a higher 
acrylic acid concentration leads to a more irregular surface on the particle. In low concentration 
(13.8 mM, Figure 3.1 (a)), although the particles are not in ideal spherical shape, the surface 
tends to be smooth. Also, the existence of a contrast difference within each individual particle 
indicates the possibility of a two-stage polymerization, in which a core was formed first during 
the reaction, followed by a second layer of polymerization, and led to a more obviously wrinkled 
surface as the concentration of acrylic acid increased. According to the cited literature, there are 
two pathways of PS nanoparticle formation in this emulsifier-free synthesis, one is the droplet 
formed from the stirring of insoluble monomer, and the other is the monomer that dissolved in 
the solvent. Before the polymerization was initiated, styrene formed the droplet from the 
vigorous stirring, while the majority of the acrylic acid was dissolved in water because of good 
solubility, and a small part of it could be blended in the styrene droplets through diffusion. Upon 
the injection of the polymerization initiator, the inner part of the particles as seen in TEM images 
was first formed from the droplets of styrene until nearly depleted during the first several hours. 
Subsequently, the dissolved acrylic acid started to get more involved and polymerized in the 
form of either outer layer or small particles that depositing on the surface of styrene 
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nanoparticles, or even caused crosslinking between smaller particles resulting in the cluster 
shape as seen in Figure 3.1 (d). The reaction was terminated while all the monomers, styrene and 
acrylic acid, were consumed eventually.
18,27,30
 The final concentration of PS nanoparticles is 
about 10 mg/ml after the filtration to remove the large agglomerations. 
 
 
Figure 3.2 TEM images of PS nanoparticles synthesized under different nitrogen flow rate: (a) 4 
sccm, (b) 1 sccm. The concentration of acrylic acid is 68.8 mM. 
 
In this synthesis, the flow rate of nitrogen which bubbles into the solution through the entire 
reaction is also considered as a key factor that influenced the morphology of PS nanoparticles. 
As see in Figure 3.2, particles synthesized under higher nitrogen flow rate (4 sccm) possess a  
smoother, spherical appearance compared to the one under low nitrogen flow rate (1 sccm). To 
the best of our knowledge, so far there is no published work that has discussed the influence of 
nitrogen flow rate on the synthesis of PS nanoparticles in the presence of acrylic acid. Based on 
our limited results, here, we generated a possible explanation. As shown in Figure 3.3, the 
polymerization of styrene with or without acrylic acid is following a radical polymerization 
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mechanism.
31,32
 Upon a radical becoming available, the carbon-carbon double bond in styrene or 
acrylic acid breaks to reach the radical and form a new single bond, therefore the polymer chain 
will grow. As the nitrogen flow bubbles in the reaction mixture, it can be a disturbance factor that 
delays or blocks the formation of radicals; hence the reaction rate is decreased as the flow rate 
increases. A slower reaction rate allows each step of the polymer chain prolongation with another 
acrylic acid or styrene molecule to happen at a more thermodynamic-kinetic-balanced site, which 
leads to relatively, smooth particle surfaces, while fast reactions drive each polymerization to 
take place at the closest site, determined primarily by kinetic preference over thermodynamic, 
which results in irregular particle surfaces. In order to deeply explore the relationship between 
nitrogen flow rate and PS particle morphology, a more systematic study focused on its 
thermodynamic and kinetic mechanism of the reaction with the use of a more accurate gas inlet 
control system will be required. 
 
Figure 3.3 The polymer chain prolongation of (a) polystyrene and (b) poly(styrene-acrylic acid) 
showing radical polymerization mechanism. 
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Figure 3.4 FT-IR spectra of (a) plain PS nanoparticle and (b) PS nanoparticles with –COOH 
functionality. 
 
The carboxyl group functionality of the PS nanoparticle was first confirmed by FT-IR as 
shown in Figure 3.4. The peaks at 2920 cm
-1
 to 2850 cm
-1
 region are corresponded to the 
asymmetric and symmetric CH2 stretching, respectively, which is numerous in polymerized 
styrene. The series of peaks within 3100-3000 cm
-1
 region can be assigned to CH stretching in 
the benzene ring, while the peaks at 1599, 1491 and 1449 represent phenyl nucleus. The most 
significant difference between Figure 3.4 (a) and (b) is the 1702 cm
-1
 peak which is attributed to 
the C=O stretching vibration in the carboxyl group of acrylic acid, therefore implying the 
successful functionalization of the PS nanoparticles.
33,34
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Figure 3.5 TEM images of (a) as-synthesized Fe3O4 nanoparticles with amine functionality, (b) 
Carboxyl group modified PS nanoparticles, (c) PS nanoparticles with Fe3O4 nanoparticles linked 
on surface, (d) higher magnification image of (c) showing detailed morphology. 
 
3.3.2 Synthesis of amine-ended Fe3O4 nanoparticles, linkage to carboxyl-ended PS beads and 
formation of magnetic porous hollow silica nanospheres (MPHSNs).  To further confirm the 
present and reactivity of carboxyl group in as-prepared PS nanoparticle, amine-ended Fe3O4 
nanoparticles (shown in Figure 3.5 (a)) with an average diameter of 10 nm were synthesized in 
polyamine media based on a method published elsewhere,
23
 then linked to PS nanoparticles 
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(shown in Figure (b)) through amine-carboxyl crosslinking under the catalysis of EDC. And this 
achieved structure can be also used as a template for the synthesis of magnetic hollow silica 
nanospheres as described in Scheme 3.1. As shown in TEM image in Figure 3.5 (c), the PS 
nanoparticles are uniformly coated with Fe3O4 particles, suggesting the carboxyl groups can be 
utilized in further reactions. However, due to this amine-carboxyl crosslinking, each Fe3O4 
particle can end up with linkages to multiple PS particles; therefore, this may cause massive 
aggregation. By comparing Figure (b) and (c), the relatively well dispersed PS nanoparticles 
became linked together to form a large conglomeration. This problem can be further accelerated 
after the formation of silica shell using the sol-gel method as shown in Figure 3.6. The resulted 
particles with approximately 20 nm thick silica layer on surface formed a large mass with sizes 
up to several microns which will be unsuitable for drug delivery application. Therefore, an 
alternative approach for achieving well dispersed, homogeneous magnetic porous hollow silica 
nanospheres should be considered. 
 
Figure 3.6 TEM images of (a) silica coated Fe3O4-PS nanoparticles and (b) higher magnification 
image of (a). 
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3.3.3 In-situ growth of Fe3O4 nanoparticles on PS particles. Since the cross-linking method of 
connecting Fe3O4 and PS nanoparticles is not practical for the preparation of MPHSNs, another 
approach in which Fe3O4 nanoparticles is directly in-situ grown on PS particles is considered. 
Instead of preparing magnetic nanoparticles beforehand, they can be synthesized and attached to 
PS particles in a simple one-pot reaction. This idea has been successfully delivered on carbon 
nanotubes,
35
 and may also work well on other organic nanostructure such as PS particles. 
Through a typical polyol mediate synthesis,
24,36
 FeCl2 and FeCl3 were used as the precursor to 
form Fe3O4 nanoparticles under basic conditions, in DEG, at an elevated temperature. Because of 
the melting point of PS (240°C), the reaction must be carried out at a lower temperature (220°C) 
than addressed in the cited literature, which may cause reduced yield and decreased size of Fe3O4 
nanoparticle. As shown in Figure 3.7, considerable amount of Fe3O4 nanoparticles with 
diameters between 5 to 10 nm were obtained after the synthesis. But instead of forming a 
homogeneous coating on PS surface as preferred, the magnetic nanoparticles were spreading 
allover the sample, especially filling in the space between PS particles. And only small portion of 
the magnetic particles is closely attached to PS surface. This may be explained as a lack of 
electrostatic attraction
37
 or affinity preference driven by surface energy
35
 between the anionic 
carboxyl-modified PS and Fe3O4. It is reasonable and logical to assume that the sample will 
result in large size mass after silica coating, which is still a derivation from our original goal of 
magnetic silica drug carriers with good dispersity, so the strategy needs to be reconsidered.  
Effort was also made to achieve cationic PS by substituting acrylic acid with allylamine but 
resulted in aggregated PS particles with no presence of amine functionality, according to FT-IR 
spectrum study. Although there are other approaches to cationic PS which involve layer-by-layer 
self-assembling of poly(allylamine hydrochloride) on PS latex, it will cause excessive particle 
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size increase and mostly used on PS in the micron size range
38
,  which is too big for cell intake 
during drug delivery. 
 
Figure 3.7 TEM images of (a) Fe3O4 nanoparticles in-situ grown on PS particles, (b) higher 
magnification of (a) showing surface detail of single PS particle. 
 
3.3.4 Preparation of mesoporous silica nanospheres based on PS templating. Since neither 
crosslinking nor in-situ growth of Fe3O4 nanoparticles on PS particles would work for 
synthesizing MPHSN with good dispersity, an alternative route should be taken as described in 
Scheme 3.2. The PS particles are first coated with mesoporous silica and the template is removed, 
then the Fe3O4 nanoparticles are in-situ grown on the silica surface through thermal 
decomposition of Fe(acac)3 in polyamine included reaction media at elevated temperatures. One 
bonus feature of this method is that the presence of polyamine enabled the synthesized particles 
to have amine functionality which can be utilized for further modification such as fluorescence 
linkage. And a secondary mesoporous silica layer or bio-degradable polymer such as 
polyethylene glycol (PEG) can be applied to reduce the toxicity and increase bio-compatibility. 
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Scheme 3.2 Synthesis approach for magnetic porous hollow silica nanospheres using PS beads as 
template and in-situ growth of Fe3O4 nanoparticles. 
 
The coating of silica on PS particles should be considered as a well-established technique 
that has been addressed in numerous literatures. However, our experience shows that a lot of 
small technical details, which are easily neglected for unimportance in this process, can be 
crucial for the success of the experiment, as discussed below. 
The mechanism of hydrolysis and condensation of alkoxysilane can be described in the 
following three reactions:
39
 
 
R represents an alkyl group, which is CH2CH3 in TEOS. Under basic condition, water dissociates 
to generate hydroxyl anion through a rapid process in order to initiate the first hydrolysis of 
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alkoxide group (OR), which is generally accepted as the limited step. After that, the hydrolysis of 
the remaining alkoxide group will be in a spontaneous manner.
39
 
Ammonia is generally used in our experiment to provide the basic condition for the 
hydrolysis of TEOS. It acts as the catalyst which increases the hydrolysis rate of OR; the 
mechanism is shown below.
39
 
 
Therefore, in the hydrolysis of alkoxysilane, water amount and pH (in form of ammonia 
amount) are considered as the key parameters for the formation of amorphous silica. Here, 
ethanol-only medium as well as an ethanol-water mixture are used in the silica coating on the PS 
process, and the effect of ammonia, surfactant CTAB, TEOS, temperature and other experimental 
details will be discussed. 
 
3.3.4.1 Ethanol-only medium for silica coating on PS nanoparticle. For the formation of silica 
shells on certain sacrificial templates, using ethanol-only reaction medium has been a widely 
applied approach. In this method, ethanol is the majority part as solvent and the limited amount 
of water comes from the concentrated ammonia solution. Reduced water amounts result in 
slower hydrolysis and condensation rates of TEOS, which can eventually keep crosslinking and 
aggregation of the silica product under control.
21,40
 In our experiments, PS nanoparticles were 
first harvested and washed through spin-dialysis, then dispersed in ethanol ultrasonically. Then 
CTAB was added to form self assembly on PS surface with enough time of stirring, followed by 
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TEOS injection and mixture was heated to 50°C. Ammonia was introduced, at last, to trigger the 
hydrolysis reaction.  
 
Figure 3.8 TEM image of silica hollow nanospheres synthesized under ammonia concentration of 
(a) and (b) 0.74 M, (c) 1.11 M, (d) 1.48 M. Inserts are showing details of small silica particles. 
Scale bar of inserts: 20 nm. 
 
First, several syntheses without CTAB were conducted with different amounts of ammonia 
hydroxide solution, (0.5, 0.75 and 1.0 ml of 14.8 M stock solution), to achieve an ammonia 
concentration of 0.74, 1.11 and 1.48 M, respectively. As shown in Figure 3.8, instead of forming 
a homogeneous layer of silica on PS, numerous small silica particles were first generated then 
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assembled on the PS surface. The possible reason is that TEOS molecules have a low affinity 
with PS without the present of a proper surfactant, so they only accumulate and hydrolyze within 
the water droplets generated from stirring which eventually resulted in small silica particles. In 
the case of lower ammonia and water concentration shown in Figure 3.8 (a) and (b), fewer silica 
particles were formed due to insufficient basic conditions and water which leads to incomplete 
hydrolysis of TEOS. In addition to the silica particles coating on PS surface, a multilayer (1~6 
layers, observed under TEM microscopy) of well-separated particles was spontaneously arranged 
around the PS particle, which is an absent phenomenon in synthesis with higher ammonia 
concentrations, probably due to relatively stronger electrostatic attraction between silica particles 
that overpowers the ionic strength of the reaction solution with less ammonia added. In higher 
ammonia concentrations, as shown in Figure 3.8 (c) and (d), more silica particles were formed 
and aggregated in an irregular manner under higher pH and water concentration.  
Besides the effect of ammonia solution, the ultrasonic treatment of PS particle with CTAB in 
ethanol at the beginning of the experiments was also found to be important for the morphology 
of the product. PS nanoparticles were first added to ethanol with CTAB and introduced to 
sonication, then magnetically stirred on hotplate before adding other chemicals and heating.  The 
duration of sonication and stirring was 20 min and 10 min for sample shown in Figure 3.9 (a), 
and 30 and 20 min for sample in Figure 3.9 (b), respectively, while all the other chemicals and 
operation remained the same between the two samples. Although the silica shell is not 
successfully formed on the PS surface, TEM images clearly indicate that longer sonication and 
stirring treatments result in single shape of small silica nanoparticles while significant amount 
silica nanorods can be observed with short treatments. Experiment pairs with different CTAB 
concentration were also performed which yielded a similar results trend. One possible 
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explanation can be that longer treatment allows CTAB to form more uniform assembly to direct 
the hydrolysis of TEOS, implying that sufficient time is required for this step in all future 
experiments, especially in high PS concentration condition.   
 
3.3.4.2 Water/ethanol mixed medium for silica coating on PS nanoparticles. Since using 
ethanol medium hasn’t been successful in our silica coating experiments, a water/ethanol mixed 
medium is the next candidate. The same water/ethanol ratio (1:4 v/v) as the one for silica coating 
on CaCO3 was applied. Considering the previous experience, the CTAB was stirred together with 
PS nanoparticles (0.5 mg/ml) for 30 min minimum, and another 20 min after TEOS was added 
before heating. And the reaction mixture was kept under 50°C for at least 24 hr to ensure 
complete hydrolysis and condensation. After calcination, as shown in Figure 3.10, a uniform 
layer of silica with mesoporous features was formed, suggesting the successful synthesis of 
mesoporous silica nanospheres with which can proceed to the next step of in-situ Fe3O4 growth., 
although this emulsifier-free method provided PS nanoparticles with good dispersity, the yield 
 
Figure 3.9 TEM image of silica nanospheres synthesized from (a) shorter and (b) longer 
treatment of sonication and stirring. 
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from each synthesis (10 mg/ml, 100 ml) is relatively low. Therefore, another approach of PS 
nanoparticle synthesis using microemulsion method was used to achieve well dispersed particle 
with higher yield and no surface functionality. 
 
Figure 3.10 TEM images of mesoporous silica nanospheres from water/ethanol ration of 1:4 v/v 
at (a) low and (b) high magnification. 
 
3.3.5 Microemulsion method using PVP as stabilizer for preparation of PS beads with large 
yield. During the microemulsion synthesis, the stabilizer must possess significant differences in 
solution property comparing to styrene in order to form the micelle.
41
 And polyvinylpyrrolidone 
(PVP) has been studied and used as a qualified stabilizer in the synthesis of PS nanoparticles for 
decades. According to the cited literature, PVP40 (average mol wt 40000 ) was selected to 
synthesized PS nanoparticle with diameter range from 200 to 500 nm,  good dispersity and no 
surface functionality.
20
 In a round-bottom flask, styrene was injected in PVP40 aqueous solution 
under vigorous magnetic stirring and nitrogen purging, then the polymerization inducer was 
added at an elevated temperature to start the reaction. As shown in Figure 3.11 (a), the resulted 
PS nanoparticles are not as well dispersed as indicated in the literature, but highly crosslinked, 
68 
 
and sized around 300 nm. We believe the reason of this crosslinking is due to the insufficient 
force of stirring; since, the micelles formed were not completely separated before the 
polymerization was triggered. The reduced size of the particles may have been caused by a 
different flask capacity and stirring conditions from the literature. However, the major 
aggregated portion of the particles can be removed by allowing the sediment to settle in 2% 
ethanol and removed through reduced pressure filtration, and the majority of the particles present 
relatively good dispersity as shown in Figure 3.11 (b). Although there is still some aggregation in 
a smaller scale (2-3 particles in each cluster), it can be considered as a great improvement 
compared to the CaCO3 nanoparticle templates mentioned in the previous chapter, which makes 
it a good candidate for the synthesis of hollow silica nanospheres. The theoretical concentration 
of the PS nanoparticles was 100 mg/ml. But due to the mass loss during filtration, the actual 
obtained concentration is about 50 mg/ml, which is still high enough for further experiments. 
 
Figure 3.11 TEM image of (a) PS nanoparticles synthesized by microemulsion method (b) PS 
nanoparticles achieved after reduced pressure filtration of (a). 
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3.3.6 Mesoporous silica coating on PS nanoparticles. By using the same method of part 3.3.4.2, 
mesoporous silica nanospheres were prepared by using a 1:4 (v/v) water/ethanol ratio under 
heated conditions with tunable shell thickness from 5 to 80 nm as shown in Figure 3.12. The 
dispersity is much better comparing to the one achieved from CaCO3 template in previous 
chapters. And the yield is good enough due to concentrated PS nanoparticles with easy 
preparation as a template.  The nanosphere with 30-50 nm silica shell was selected for in-situ 
growth of Fe3O4 nanoparticles due to medium thickness, relatively good dispersity, and proper 
resistance against ultrasonic treatment during the synthesis.  
 
Figure 3.12 TEM images of mesoporous hollow silica nanospheres from different TEOS/PS ratio 
(w/w): (a) 0.75, (b) 1.56, (c) 2.99, (d) 6.22. 
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Figure 3.13 TEM images of silica coated PS nanoparticle (a) before and (b) after calcination 
treatment for template removal. 
 
In this silica coating procedure, we also found out that under the absence of TEOS, ammonia 
hydroxide cannot co-exist with CTAB. No matter which one of these two was added first into the 
reaction mixture, the addition of the other one will cause visible aggregation of PS particles 
which turns the lightly milky dispersion of PS to millimeter size pieces in clear solution within 
one minute. Upon this discovery, the order of chemicals should always be 
CTABTEOSammonia, in which ammonia hydroxide is applied last, to simply initiate the 
hydrolysis of TEOS while all other chemicals and heating condition have been ready.  In addition, 
for the removal of both templates, CTAB and PS, calcination in air can be more convenient and 
effective than first dissolving away CTAB in refluxing ethanol then organic solvent (toluene, 
dichloromethane, chloroform, and acetone) treatment for PS removal.  The heat during 
calcination does not damage the morphology and dispersity of the hollow silica nanospheres as 
we expected.
42-44
 To support this point, TEM images of silica coated PS particles before and after 
6 hr 600°C calcination are shown in Figure 3.13. By comparing Figure 3.13 (a) and (b), besides 
some small silica particles caused by overdosed TEOS, all the hollow silica nanospheres are very 
71 
 
well separated from each other, ingnoring the few broken nanospheres, most likely caused by the 
sonication during TEM sample preparation. The dispersity of the nanospheres is not affected by 
calcination treatment. 
 
3.3.7 In-situ growth of Fe3O4 nanoparticles on mesoporous silica nanospheres, synthesis and 
XRD study. As Fe3O4 nanoparticles can be prepared through thermal decomposition of iron(III) 
acetylacetonate (Fe(acac)3) as the precursor in an amine-rich polyamine medium,
23
 which serves 
as the solvent, reducing agent and capping ligand, a similar method was adapted here for the 
purpose of in-situ growth of Fe3O4 nanoparticles on the surface of silica nanospheres with amine 
functionality. The silica nanospheres were, first, dispersed in water under sonication, then mixed 
with Fe(acac)3 and polyamine reaction solvent, and subjected to controlled heating. The first 
heating segment was set at 120°C for at least 20 min for complete evaporation of water, then 
various heating curves were explored to obtain uniform magnetic particle coating with a 
relatively large particle size and stable superparamagnetism property. The product was washed 
with acetone using magnetic separation, and then dried under vacuum. 
First TETA with boiling point of 266°C was used as the solvent. After the evaporation of 
water, the reaction mixture was first heated to 210°C to start the decomposition of Fe(acac)3 then 
kept at 260°C for various amounts of time. As seen in the TEM images in Figure 3.14 (a) and (b), 
a layer of  Fe3O4 nanoparticles were successfully formed on the silica shell, with similar coating 
density.  In addition, it is clear that samples synthesized from longer reaction time (Figure 3.14 
(b)) presents Fe3O4 nanoparticles with larger diameters, therefore stronger superparamagnetism 
property, compared to the sample from shorter reaction time (Figure 3.14 (a)). Both samples can 
be easily attracted by bench magnet during the first several cycles of washing, but the magnetic 
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property diminished after being immersed in acetone for more than 24 hr. The XRD spectrum 
shows no obvious lattice, indicating defective crystals. It may be explained that the reaction 
temperature is not high enough for complete decomposition of the precursor and formation of 
indefective Fe3O4 crystals through TETA reduction. Proper polyamine solvent with higher 
boiling point shall be required. 
 
Figure 3.14 TEM images of Fe3O4 nanoparticle coated silica nanospheres in TETA with reaction 
time of (a) 1 hr and (b) 3 hr. 
 
Therefore, TEPA with boiling point of 340°C and higher density of imine (-NH-) group as 
reducing agent was then used for the reaction of in-situ Fe3O4 nanoparticle formation to achieve 
higher reaction temperature. After 1 hr of reaction under 300°C, numerous magnetic particles 
were formed (Figure 3.15 (a)) and the sample can be attracted by a bench magnet after being 
soaked in acetone for days. However, the XRD spectrum (Figure 3.15 (c)) reflected the majority 
of the magnetic particles as Fe instead of Fe3O4, and will only present ferromagnetism property, 
which is not preferred for drug delivery purposes. The possible reason can be that the reduction 
ability of TEPA at 300°C is so strong that Fe
3+
 is directly reduced to Fe
0
 without forming Fe
2+
. 
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On the another hand, TEG with boiling point 314°C can also be used for the in-situ growth of 
magnetic nanoparticles with a much larger diameter (Figure 3.15 (b)) and stable Fe3O4 crystal 
structure (Figure 3.15 (c)) through the same experimental procedure at 300°C. These results 
inspired the idea of combining the two solvents, TEPA and TEG, in a certain ratio in order to 
partially weaken the reducing power of TEPA and therefore achieve Fe3O4 particles with larger 
diameter and amine functionality. 
 
Figure 3.15 TEM images of magnetic nanoparticles from the synthesis by using (a) TEPA and (b) 
TEG as reaction solvent; and (c) XRD spectra of samples, from top: synthesis with TEPA, Fe 
standard, synthesis with TEG, Fe3O4 standard. 
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First, TEPA/TEG=1:1 (v/v) ratio was used and the reaction was kept at 300°C for 1 hr which 
only resulted in Fe nanoparticles, confirmed under XRD, indicating not enough dilution of TEPA. 
By further reducing the proportion of TEPA down to 10~20% (v/v), Fe3O4 particles can be 
eventually achieved. It was also discovered that the first heating stage, in which was set between 
110°C and 150°C to allow the evaporation of water, was very important for the yield of magnetic 
nanoparticles. By increasing time duration of this segment at the temperature which is still not 
high enough for formation of Fe3O4 nanoparticles, more of the Fe(acac)3 precursor molecules can 
be dissolved and integrated to the mesoporous surface of silica, and even diffuse into the hollow 
space through porous channels and form magnetic particles inside the shell. As seen in Figure 
3.16 in which the sample was heated at 120°C for 3 hr before ramping to the next segment, the 
outer surface of the silica nanospheres, especially for the highlighted ones, is comparatively 
smooth while most of the magnetic nanoparticles are filled inside the silica shell.  
 
Figure 3.16 TEM image of (a) magnetic nanoparticle decorated silica nanospheres (highlighted 
in red dashed circles) and (b) higher magnified image showing magnetic particles filling inside 
silica shell. 
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Meanwhile, a combination of TETA and TEG was also applied to a series of experiments 
under 280°C, which is the highest temperature that the mixed solvent can get. The obtained 
magnetic nanoparticles were confirmed to be Fe3O4 through XRD. However, due to the same 
reason of relatively low reaction temperature, the magnetic nanocrystals were defective and the 
magnetic property was significantly reduced after several days. Thus so far the combination of 
TEPA and TEG is still the better solvent for in-situ growth of superparamagnetic Fe3O4 
nanoparticles with amine functionality on mesoporous hollow silica nanospheres. 
 
Figure 3.17 XRD spectrum of (a) as-prepared magnetic nanoparticles on silica and (b) Fe3O4 
standard. 
 
The crystalline structure of as-prepared Fe3O4 nanoparticles on silica was examined by XRD.  
By comparing the two spectra in Figure 3.17, the peaks of Fe3O4 nanoparticles on mesoporous 
silica nanospheres synthesized from TEPA/TEG combined solvent (a) match the standard 
76 
 
spectrum of Fe3O4 crystal (b), confirms that the achieved magnetic nanoparticles are indeed 
Fe3O4. 
 
3.3.8 Magnetic property of as-prepared magnetic hollow silica nanospheres. The magnetic 
properties of the silica with in-situ growth of Fe3O4 nanoparticles were measured by SQUID. 
Zero-field-cooled (ZFC) and field-cooled (FC) magnetization data were measured in the 
temperature range of 5–300 K, as shown in Figure 3.18 (a). In the ZFC measurement, the initial 
field was set to zero when cooling the sample from 300 to 5 K. A field of 50 Oe was applied and 
the magnetization was measured as the sample was heated from 5 to 300 K. In FC measurement, 
a field of 50 Oe was applied as the sample was cooled from 300 to 5 K and the magnetization 
was measured as the sample was heated from 5 to 300 K in the field of 50 Oe. The ZFC curve 
shows a maximum at 73.3 K, which is the blocking temperature (TB) of the magnetic 
nanoparticles in the sample. The sample exhibits superparamagnetism properties at temperatures 
above TB, meaning it they can be attracted by a magnetic field but retain no residual magnetism 
when the magnetic field is removed. To ensure these features, the field-dependent hysteresis loop 
was measured at room temperature, which is close to the condition that most nano-medicine 
applications would carry out, as shown in Figure 3.18 (b). The hysteresis loop at 300 K shows a 
saturation magnetization of 9.78 emu/g (at the field of 20 000 Oe) and absence of coercivity, 
which confirms superparamagnetic behavior. The absence of coercivity in the hysteresis loop at 
300 K indicates a superparamagnetic behavior.  
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Figure 3.18 Magnetic properties of the Fe3O4 decorated silica: (a) temperature dependence of 
magnetization at ZFC and FC conditions; (b) hysteresis loops 300 K. 
 
3.3.9 BET analysis. Information regarding surface areas and pore volume for the silica 
nanospheres before and after in situ decoration of Fe3O4 was obtained by measuring N2 
adsorption-desorption isotherms and pore size distribution was calculated by BJH method. As 
seen in Figure 3.19 (a), both the isotherms have sharp inflection, indicating the sample was able 
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to maintain a uniform porous structure after the decoration of Fe3O4. The loop area is smaller for 
the sample with Fe3O4 because the small particles are occupying the porous space on the silica 
surface and, therefore, reduce the pore volume. Furthermore, the peak pore diameter is 3.37 nm 
for pure silica nanospheres and 3.17 nm for Fe3O4-silica, indicating the BJH pore size 
distribution in Figure 3.19 (b) shows that the in-situ growth of Fe3O4 doesn’t significantly 
change the size of the pore, but only reduces porous volume. 
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Figure 3.19 (a) Nitrogen absorption-desorption isotherms and (b) Pore size distribution 
calculated using BJH method of mesoporous silica nanospheres and after in-situ growth of 
magnetic nanoparticles.  
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3.3.10 FT-IR spectrum. The amine functionality of as-prepared silica nanospheres with in-situ 
growth of Fe3O4 nanoparticles was confirmed by FT-IR. By comparing the sample synthesized 
from TEG and TEPA/TEG as shown in Figure 3.20, the peak at 1600 nm
-1
 is corresponded to the 
bending vibration of N-H bond,
32,34
 confirming the existence of amine group for further 
modification and functionalization. 
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Figure 3.20 FT-IR spectra of silica nanospheres with in-situ growth of Fe3O4 nanoparticles by 
using (a) TEG and (b) combination of TEPA and TEG, as reaction solvent. 
 
3.3.11 Fluorescence modification using water soluble quantum dots. Hydrophilic CdSe/ZnS 
quantum dots with carboxyl functionality were successfully conjugated on the Fe3O4 decorated 
mesoporous silica prepared from TEPA/TEG mixed media through carboxyl-amine reaction 
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under the catalysis of zero-length crosslinker EDC. As shown in Figure 3.21, after thorough 
washing in order to remove excess and physically adsorbed quantum dots on the MPHSNs, the 
nanoparticle presents bright fluorescence comparing to the dark background, indicating solid 
covalent binding between MPHSN and quantum dot, therefore confirms the availability of the 
amine groups on the magnetic silica after the in situ decoration of Fe3O4. 
 
Figure 3.21 Fluorescence image of MPHSN linked with CdSe/ZnS quantum dots with maximum 
emission at 595 nm using a 40x objective lens. 
 
3.4 Conclusion 
In this chapter, two different approaches were employed to synthesize magnetic porous 
hollow silica nanospheres base on PS template for the void interior. Carboxylic functionalized PS 
nanoparticles were synthesized for the attachment of amine-modified magnetite nanoparticles, 
followed by mesoporous silica coating and template removal. In the other approach, hollow 
mesoporous silica nanospheres were first prepared based on PS templating and in situ growth of 
magnetite nanoparticles was successfully achieved using thermal decomposition of organic iron 
precursor in polyamine/polyalcohol mixed media. After this convenient, one-pot synthesis, the 
resulted product exhibited good superparamagnetism properties and available amine groups for 
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further functionalization, such as fluorescence conjugation using quantum dots, indicating 
promising potential for multi-functional drug delivery and imaging. 
 
3.5 References 
(1) Lu, A.-H.; Salabas, E. L.; Schüth, F. Angew. Chem. Int. Ed. 2007, 46, 1222. 
(2) Yang, P.; Gai, S.; Lin, J. Chem. Soc. Rev. 2012, 41, 3679. 
(3) Tang, F.; Li, L.; Chen, D. Adv. Mater. 2012, 24, 1504. 
(4) Feng, J.; Song, S.-Y.; Deng, R.-P.; Fan, W.-Q.; Zhang, H.-J. Langmuir 2009, 26, 3596. 
(5) Gai, S.; Yang, P.; Ma, P. a.; Wang, D.; Li, C.; Li, X.; Niu, N.; Lin, J. J. Mater. Chem. 2011, 
21, 16420. 
(6) Feng, J.; Fan, W.-Q.; Song, S.-Y.; Yu, Y.-N.; Deng, R.-P.; Zhang, H.-J. Dalton 
Transactions 2010, 39, 5166. 
(7) Zhao, W.; Chen, H.; Li, Y.; Li, L.; Lang, M.; Shi, J. Adv. Funct. Mater. 2008, 18, 2780. 
(8) Liu, J.; Qiao, S. Z.; Budi Hartono, S.; Lu, G. Q. Angew. Chem. Int. Ed. 2010, 49, 4981. 
(9) Zhu, Y.; Fang, Y.; Kaskel, S. J. Phys. Chem. C 2010, 114, 16382. 
(10) Huang, S.; Yang, P.; Cheng, Z.; Li, C.; Fan, Y.; Kong, D.; Lin, J. J. Phys. Chem. C 2008, 
112, 7130. 
(11) Martín-Saavedra, F. M.; Ruíz-Hernández, E.; Boré, A.; Arcos, D.; Vallet-Regí, M.; 
Vilaboa, N. Acta Biomater. 2010, 6, 4522. 
(12) Yiu, H. H. P.; Niu, H.-j.; Biermans, E.; van Tendeloo, G.; Rosseinsky, M. J. Adv. Funct. 
Mater. 2010, 20, 1599. 
(13) Giri, S.; Trewyn, B. G.; Stellmaker, M. P.; Lin, V. S. Y. Angew. Chem. Int. Ed. 2005, 44, 
5038. 
(14) Lee, J.-H.; Jun, Y.-w.; Yeon, S.-I.; Shin, J.-S.; Cheon, J. Angew. Chem. Int. Ed. 2006, 45, 
8160. 
(15) Lee, J. E.; Lee, N.; Kim, H.; Kim, J.; Choi, S. H.; Kim, J. H.; Kim, T.; Song, I. C.; Park, S. 
P.; Moon, W. K.; Hyeon, T. J. Am. Chem. Soc. 2009, 132, 552. 
(16) Lee, J. E.; Lee, D. J.; Lee, N.; Kim, B. H.; Choi, S. H.; Hyeon, T. J. Mater. Chem. 2011, 
21, 16869. 
(17) Chang, C. H.; Son, P. S.; Yoon, J.-A.; Choi, S.-H. J. Nanomater. 2010, 2010. 
(18) Dong, H.; Lee, S.-Y.; Yi, G.-R. Macromol. Res. 2009, 17, 397. 
(19) Hsiao, S.-C.; Ou, J.-L.; Sung, Y.; Chang, C.-P.; Ger, M.-D. Colloid. Polym. Sci. 2010, 288, 
787. 
(20) Qi, G.; Wang, Y.; Estevez, L.; Switzer, A. K.; Duan, X.; Yang, X.; Giannelis, E. P. Chem. 
Mater. 2010, 22, 2693. 
(21) Yuan, J.; Wan, D.; Yang, Z. J. Phys. Chem. C 2008, 112, 17156. 
(22) Li, J.-M.; Ma, W.-F.; Wei, C.; Guo, J.; Hu, J.; Wang, C.-C. J. Mater. Chem. 2011, 21, 
5992. 
(23) Qu, H.; Ma, H.; Riviere, A.; Zhou, W.; O'Connor, C. J. J. Mater. Chem. 2012, 22, 3311. 
(24) Feldmann, C.; Jungk, H.-O. Angew. Chem. Int. Ed. 2001, 40, 359. 
(25) Maity, D.; Kale, S. N.; Kaul-Ghanekar, R.; Xue, J.-M.; Ding, J. J. Magn. Magn. Mater. 
2009, 321, 3093. 
82 
 
(26) Wan, J.; Cai, W.; Meng, X.; Liu, E. Chem. Commun. 2007, 5004. 
(27) Wang, P. H.; Pan, C. Y. Colloid. Polym. Sci. 2002, 280, 152. 
(28) Musyanovych, A.; Rossmanith, R.; Tontsch, C.; Landfester, K. Langmuir 2007, 23, 5367. 
(29) Holzapfel, V.; Musyanovych, A.; Landfester, K.; Lorenz, M. R.; Mailänder, V. Macromol. 
Chem. Phys. 2005, 206, 2440. 
(30) Yamamoto, T.; Nakayama, M.; Kanda, Y.; Higashitani, K. J. Colloid Interface Sci. 2006, 
297, 112. 
(31) Pojman, J. A.; Willis, J.; Fortenberry, D.; Ilyashenko, V.; Khan, A. M. J. Polym. Sci., Part 
A: Polym. Chem. 1995, 33, 643. 
(32) McMurry, J. Organic Chemistry; Fifth ed.; Brooks/Cole, 2000. 
(33) Silversterin, R. M., Webster, F. X. Spectrometric identification of organic compounds; 6th 
ed.; John Wiley & Sons, Inc., 1997. 
(34) Nakannishi, K. Infrared absorption spectroscopy - practical; Holden-Day, Inc., San 
Francisco and Nankodo Company Limited, Tokyo, 1962. 
(35) Wan, J.; Cai, W.; Feng, J.; Meng, X.; Liu, E. J. Mater. Chem. 2007, 17, 1188. 
(36) Cai, W.; Wan, J. J. Colloid Interface Sci. 2007, 305, 366. 
(37) Gao, C.; Li, W.; Morimoto, H.; Nagaoka, Y.; Maekawa, T. J. Phys. Chem. B 2006, 110, 
7213. 
(38) Kato, N.; Schuetz, P.; Fery, A.; Caruso, F. Macromolecules 2002, 35, 9780. 
(39) Chen, S.-L.; Dong, P.; Yang, G.-H.; Yang, J.-J. Industrial & Engineering Chemistry 
Research 1996, 35, 4487. 
(40) Cao, S.; Jin, X.; Yuan, X.; Wu, W.; Hu, J.; Sheng, W. J. Polym. Sci., Part A: Polym. Chem. 
2010, 48, 1332. 
(41) Antonietti, M.; Heinz, S.; Schmidt, M.; Rosenauer, C. Macromolecules 1994, 27, 3276. 
(42) Lee, K. K.; Kang, Y. C.; Jung, K. Y.; Kim, J. H. J. Alloys Compd. 2005, 395, 280. 
(43) Cui, H.; Zayat, M.; Levy, D. J. Sol-Gel Sci. Technol. 2007, 41, 313. 
(44) Balencie, J.; Levy, L.; Hochepied, J. F. Mater. Chem. Phys. 2008, 112, 546. 
 
 
 
 
83 
 
Part II: Semiconductive nanostructure for biosensor application 
 
Chapter IV: Introduction 
 
During the latest years, the demand of prompt and accurate detection method for biological 
molecule has become more and more significant for the purpose of biological study, medicine 
application and safety inspection. Numerous of conventional methods have been developed and 
used for detection and analysis of molecules such as DNA, enzyme, structural protein and lipid 
for decades, but with drawbacks of high equipment expense, long analysis time or sensitivity 
limitation. Meanwhile, since most of the biological molecules and complex are in nanometer 
scale, the studies of nanomaterials and biology/biomedicine have been sharing a lot of common 
interest and interaction with each other, therefore the new class of nano-biosensor is being 
derived. As being within the same size range, nanomaterials based sensing devices are more 
capable of picking up the signal of biological analyte with higher sensitivity upon contact, thank 
to the high surface-to-volume ration. Also, the vast development of nanoscience and 
nanotechnology has built solid foundation for designing the nanomaterial and device structure to 
suit our need for the detection of different analyte. So far, nanomaterials based biosensor has 
been an extremely active research field in the past decade that various nanomaterials, including 
nanowire, nanoparticle and other more sophisticated combined structure, are employed for the 
detection of biological materials through different pathways according to their structure and 
function, and generate various formats of output signal simultaneously, including magnetic, 
fluorescent, electrochemical and so on. Among all the materials, semiconductive nanowire with 
field-effect property is one of the most frequently studied candidates for biosensing detection 
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based on electric signal generated from biological molecules with charge. The device is 
immobilized on circuit chip with highly designable structure and easy for handling and 
observation. Also, the integration with microfluidic channel makes it more convenient for the 
detection of solution/dispersion samples, and therefore greatly enhances the potential for 
practical application.  
In this chapter, a comprehensive introduction of biosensors based on nanomaterials is 
provided, categorized by material structures including nanoparticle and nanowire. First several 
nanoparticle base biosensors are introduced. Then we focus on semiconductive nanowire field-
effect transistors for biosensor in the aspects of different materials and their modification as well 
as applications in biosensing.  
 
4.1 Nanoparticles based biosensors 
The applications of nanoparticles for biosensors have been extensively studied, including 
fluorescence, colorimetric, electrochemical sensing and so on. Besides, there are numerous 
works about fabrication of multifunctional platform that combines the feature of drug delivery, 
bio-targeting and sensing, fluorescence imaging, and even magnetic property all together in 
single nanoparticle, but will be beyond the content of this chapter.  
 
4.1.1 Fluorescence sensing  
Quantum dots are semiconductive nanocrystals with size below 10 nm and high quality 
fluorescence property. Comparing to conventional organic fluorescent dyes, quantum dots have 
been famous for the easy excitation, tunable, narrow and symmetric emission spectrum
1
, which 
are all preferable character for serving as fluorescence probe in bio-detection. One of the earliest 
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reported works of using nanomaterials for bio-sensing purpose was reported in 1998. Both Nie
2
 
and Alivisatos’s3 groups used different color emitting core-shell quantum dots conjugated with 
selected surface functionality to detect the location of targeted protein through either electrostatic 
force/hydrogen bond or ligand-receptor interactions such as biotin-avidin and antibody-antigen, 
and multicolor dye images under single excitation were presented. These studies exhibited the 
outstanding advantage of quantum dots for fluorescence labeling and detection, also 
demonstrated the photochemical stability of quantum dot in biological environment. As water 
solubility being vital for biological application, the as-prepared hydrophobic quantum dot was 
converted to hydrophilic by silica coating
3
 or mercaptoacetic acid capping
2
 to increase bio-
compatibility. Soon the research of quantum dot bio-labeling has been developing significantly, 
majorly focused on the surface functionalization that is adaptable to the target molecules while 
enhancing biological buffer compatibility of the quantum dots, including ligand exchange
4
 and 
amphiphilic polymer encapsulation
5
 after which further functionality will take place through 
crosslinkers to complete bio-molecule modification. So far, quantum dot has been conjugated 
with antibody and peptide for the imaging and detection of virus infection,
6
 cancer cell
5,7,8
 and 
cell membrane proteins.
9,10
 In addition, ssDNA-quantum dots conjugation has been widely 
explored for fluorescence resonance energy transfer (FRET) biosensor
11-13
 in which hybridization 
of the targeted DNA triggers the fluorescence of quantum dots that is originally quenched. 
However, being highly capable of different surface functionalization also presents drawback 
for bio-sensing application. Since quantum dot is multivalent which means the category and 
number of linked molecules varies, it is hard to control the stoichiometry, orientation and 
conformation of the conjugation. So the relationship between analyte concentration and output 
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signal strength is difficult to determine. Therefore it is more suitable for qualitative imaging 
rather than quantitative sensing and analysis.
14
  
 
4.1.2 Colorimetric sensing 
The principle of colorimetric sensor is the recognizable color change of metal nanoparticle, 
mostly gold or silver, under different aggregation states.
15,16
 Metal nanoparticles are first linked 
with either oligonucleotide, aptamer or other organic complex that specifically interact with 
targeted molecules and then result in aggregation and the change of color can be quantified 
through spectrophotometer. This sensing approach was first applied to lead ion detection
17,18
 by 
using “DNAzyme” which is literally a DNA strand with Pb2+ binding site that cleaves into two 
parts upon contact with Pb
2+
. The resulted DNA strands hybridize with complementary sequence 
from neighboring particles and eventually cause aggregation. Colorimetric cocaine detection was 
also carried out by using cocaine aptamer linked gold nanoparticles. The nanoparticles were 
originally aggregated because of the pairing of conjugated oligonucleotide, but became 
disassembled with the present of cocaine as the aptamers binding to cocaine molecules and 
releasing the nanoparticles from each other, inducing color change of blue to red, of which the 
rate of change increased with cocaine concentration in the range of 50 to 500 µM. Recently, the 
application colorimetric nanoparticle sensors has been widely expanded to the detection of 
multiple heavy metal and other hazardous ions, including, but not limited to, copper,
19
 mercury,
20
 
silver,
21
 cobalt,
22
 arsenic
23
 and cyanide
24
.   This nanoparticle based sensor has also been 
investigated for detection of peptides such as enzyme and biomarker,
25
 as well as targeted 
DNA/RNA sequence without amplified through PCR (polymerase chain reaction) for genetic 
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diagnosis of decease and pathogen, such as cancerous cell,
26,27
 Escherichia coli,
28
 and 
Salmonella bacteria.
29
 
  
4.1.3 Electrochemical sensing 
Metallic and semiconductive nanoparticles can be immobilized on electrode and perform as 
electrochemical sensor through the specific interaction between particle surface functionality and 
analyte that causes conductivity change. The increased surface area comparing to conventional 
electrodes remarkably enhances the efficiency of electron transfer from analyte and improves 
detection sensitivity.
30-32
 Numerous studies have been reported about using nanoparticle 
electrochemical sensor for the detection of nucleic acid. Mirkin et al
33
 developed a DNA array 
detection method started with short oligonucleotide functionalized SiO2 film deposited between 
two electrodes. Colloidal gold nanoparticles modified with oligonucleotide were then applied 
and bind to the SiO2 film with the present of target DNA sequence through hybridization since 
both oligonucleotides were designed to be complementary with part of target DNA. Subsequently, 
silver deposition on the colloidal gold was introduced, functioned as signal amplifier to achieve 
detection sensitivity down to 500 fM with a point mutation selectivity of about 100000:1.
33
 
Detections of proteins or peptides have also been realized by using antibody
34,35
 or aptamer
36-38
 
based on similar principle. Nanoparticle electrochemical sensor is also adapted to enzyme based 
sensing by immobilizing enzyme molecules on particles for the detection of substrate 
concentration or enzyme activity. One popular application is test of glucose concentration by 
using glucose oxidase functionalized particles, including platinum,
39
 gold
40,41
, magnetite
42
 and so 
on. As redox reaction, the oxidation of glucose triggers electron transfer in the enzyme-
nanoparticle complex and the signal is recorded by voltametric analyzer.
32
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4.2 Nanowire based biosensors 
Semiconductive nanowire (NW) has been widely employed in various applications involving 
solar cell, piezoelectric, nanophotonic, supercapacitor, chemical/ biological sensing and so on. 
The investigation of using nanowire for biosensing is one of the most appealing topics in both 
nanoscience and biomedicine, and became thrived with the fast development of other micro-
fabrication techniques such as high-precision lithography and microfluidic channel, as well as 
multi-probe/multi-channel source meter and recording system. NW based field effect transistor 
(FET) has been demonstrated to be a powerful weapon with promising potential for the detection 
of different biological agents, including peptide/protein, nucleic acid, enzyme, toxin, bacteria and 
virus. 
 
Scheme 4.1 Schematics showing the structure and working mechanism of nanowire FET based 
biosensor.  
 
4.2.1 Principle of nanowire field effect transistor (FET) in biosensing 
As shown in Figure 4.1, a typical NW FET can be described as semiconductive NW 
connected to two metal electrodes, source (S) and drain (D), which are connected to sourcemeter 
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to form a circuit; A third electrode, gate (G), is capacitively coupled with NW through a thin 
dielectric layer.
43
 The conductance of the NW can be switch on/off, and enhanced in “on” 
direction by the bias applied on the gate electrode controls.  For n-type semiconductor in which 
electron is the charge carrier, depletion of carriers happens under negative gate voltage and 
therefore conductance is reduced, while applying positive gate voltage generates accumulation of 
carrier and increases the conductance. And p-type semiconductor using vacancy as charge carrier 
behaves in the exact opposite way. An FET device should exhibit immediate response in 
conductance with high sensitivity against the change of gate voltage to be qualified as biosensor 
candidate. Hence measurements of source-drain conductance/current (Ids) vs. gate voltage (Vg) 
are necessary for the evaluation of each device in order to locate the high Ids/Vg sensitivity 
region which is ideal for biosensing detection.  Since bio-molecules usually carry characteristic 
charges, for example, the charge of protein molecules can be predetermined by the amino acid 
composition and pH of buffer environment, and DNA carries negative charge of which the value 
is proportion to the chain length, these charge carrying molecules function as gate voltage on 
NW during detection. In addition, some FETs naturally stays in “off” status or low sensitivity 
zone under zero gate voltage and external gate bias will be required to ensure the device is 
working at the best performance.
43
  
Besides the electric property of the FET device, another fundamental issue for biosensing is 
the specific binding between the nanowire and analyte molecule in solution environment; so that 
the nanowire is only picking up the signal from target molecules, not other agents in the solution. 
This binding is always realized by immobilizing molecular receptors such as antibody, aptamer 
and nucleic acid chain with complementary sequence on nanowire surface modified with 
appropriate linker to capture only the targeted molecule in solution. Therefore choosing the right 
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linker according to the nanowire material and functionality of receptor molecule has been the key 
factor in the preparation of nanowire biosensor.
44
  
 
4.2.2 Semiconductive nanowires for biosensing  
Semiconductor nanowire is one of the largest families of material in nanoscience with rapidly 
expanding territory. A huge selection of material being semiconductive in bulk state can be 
prepared in nanowire with nanoscale diameter and high aspect ratio through either top-down or 
bottom up approach. In top-down approach, nanowires are achieved by applying 
chemical/physical etching through micro-fabrication lithography on planar substrate to 
selectively remove atoms or molecules. This approach always results in highly ordered nanowire 
with designable measurements, but with disadvantage of elevated cost, limited output and 
extended preparation time, suggesting unsuitability for industrial fabrication. The other approach, 
bottom up method requires assembly of atom/molecule physically or chemically through vapor 
deposition, solution based synthesis or template directed synthesis, resulting in substantial yield 
with high purity and reduced cost, controllable electrochemical property from intentional doping 
and formation of junction structure, and capability of scaled up synthesis that are favored feature 
of industrial application. 
45
 
So far, metal oxide, silicon, carbon nanotube/graphene, conductive polymer and group III/V 
compounds have all been successfully synthesized in nanowire/belt/tube with various diameter 
and length for the device fabrication of biological sensing.
46
  
 
4.2.2.1 Indium Oxide (In2O3) nanowire based biosensor 
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Indium oxide nanowire always exhibits excellent transistor behavior with strong gate 
dependence that makes it qualified candidate for chemical and biological sensing.
47
 Single 
crystalline In2O3 nanowire is usually prepared by either thermal evaporation or chemical vapor 
deposition (CVD) method that use ultra high purity (99.9999%) In2O3 and indium metal powder 
as precursor, respectively. Typically, the precursor and is placed in a ceramic boat located in the 
heating center of a horizontal tubular furnace. Silicon substrate, seeded with nanosized indium 
particle
48
 or not
49,50
, deposited with noble metal nanoparticle as catalyst,
51-53
 is put downstream 
of the precursor to collect product. Effective evaporation of the precursor requires temperature 
above 1000°C and the nucleation and deposition happens between 750-800 °C for nanowire 
growth on substrate under argon flow as the mass transport media. And the residual amount of 
oxygen in the gas system is essential for the oxidization of indium and the initiation of nanowire 
growth.
48
 An alternative of preparing In2O3 nanowire in CVD method is introducing InAs as the 
source material which results in Arsenic-doped bi-crystalline nanobelt through a fast-heating-
vapor-trapping method. In this method, silicon substrate with Au catalyst is placed close on the 
top of source material instead of downstream, and highly concentrated vapor from source 
material is generated upon a steep temperature rise to 550°C, which increase the nanowire 
yield.
54
 In addition, laser ablation approach is an improved CVD method for the synthesis of 
In2O3 nanowire. Au nanoparticle in diluted aqueous solution is deposited on silicon substrate, 
serves as catalyst for the laser ablation promoted In2O3 nanowire growth using InAs target as 
source material.
55-57
 
In order to covalently link receptor molecules to the surface of In2O3 nanowire for biosensing, 
bi-functional linkers with phosphonic acid group on one end and conventional functionality such 
as carboxylic acid on the other end is suggested.
58
 It has already been demonstrated by studying 
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4-(1,4-dihydroxybenzene)butyl phosphonic acid (HQ-PA) modified In2O3 in cyclic voltammetric 
and chronoamperometric measurements that phosphonic acid group is able to form robust 
covalent bond with In2O3 through room temperature incubation and remain stable under various 
conditions.
59
 Based on this functionalization platform, In2O3 nanowire based FET that 
conjugated with specified antibodies has been utilized for the detection against a variety of bio-
species, including prostate-specific antigen
58
 and virus capsid protein
55
, as well as distinguishing 
detection of multiple cancer biomarkers.
60
 
 
4.2.2.2 Zinc oxide (ZnO) nanowire based biosensor 
Comparing to In2O3, ZnO is a much more common and dominant material in both 
nanoscience research and commercialized product. Semiconductive ZnO with a wide band gap 
of 3.37 eV possess great electronic and optical property with promising potential applications 
such as gas sensor, solar cell, photodetector and FET.
61
 One dimensional nanostructure ZnO can 
be prepared through either gas phase or solution phase growth and resulted in various structure, 
including nanosized belt, wire, rod, whisker and tube.
62
 Thermal evaporation,
63-65
 metal-organic 
vapor-phase epitaxy,
66-68
 chemical vapor deposition
69-71
 and pulse laser deposition
72-74
 are all 
efficient gas phase approaches using zinc, ZnO or organic zinc precursors for ZnO nanowire and 
nanorod growth with different promoting energy source and substrate. In solution phase 
approaches, hydrothermal is the most common method that using Zn(II) salt aqueous solution as 
the precursor and growth environment to achieve well-aligned ZnO nanowire. The density of 
nanowire can be adjusted by solution concentration and substrate patterning using e-beam 
lithography.
75
 Template directed electrodeposition is another functional solution method by using 
anodic aluminum oxide (AAO) membrane as template to obtain ordered ZnO nanowire array. 
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Usually, Zn nanowire is first achieved through the deposition procedure in solution and then 
oxidized to ZnO by heating in air after template removal. 
76,77
 
The functionalization of ZnO nanowire can be very facile since its high isoelectric point 
(pI=9.5) allows receptor molecules such as acidic enzymes with much lower pI to stably attach 
through electrostatic interaction.
78,79
 Glucose oxidase (GOD, pI=4.2) is the most studied enzyme 
that immobilized on ZnO NW surface through this convenient physical adsorption for glucose 
detection. 
78-80
 ZnO NW FET present excellent sensitivity against the redox reaction of glucose 
on attached GOD molecules and detection limit has been pushed down to 1µM at a signal-to-
noise ratio of 3.
80
 ZnO can also be covalently modified with linker 3-(trimethoxysilyl) propyl 
aldehyde and conjugated to antibody with hydrazide ends for real time detection of antigen. 
81,82
 
Furthermore, an interesting investigation revealed the high bio-compatibility of ZnO nanowire 
that the cell remained active and good reproductive ability after cultured with low concentration 
of NW for 48 h, indicating the potential application of cellular sensing biological engineering of 
ZnO NW.
83
 
 
4.2.2.3 Silicon nanowire based biosensor 
As the key element for semiconductor material with applications that influence our life from 
every corner, silicon plays the irreplaceable role in material science and technology. Silicon 
nanostructures, including thin film, nanocrystals, nanowire/tube/belt and various assembly 
structures have been exploited and adapted to the research of photovoltaic solar cell, light 
emission, bio-medicine and sensing.
43,44,84
 One dimensional silicon nanowire with FET property 
can be prepared through multiple approaches. CVD methods using silane, SiH4 and Si2H6 or 
halogen substituted silane, SiH2Cl2 and SiCl4 as precursor is the most commonly used technique 
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for vertical aligned silicon nanowire synthesis. Under the catalysis of Au nanoparticle on silicon 
substrate, the nanowire growth follows a vapor-liquid-solid mechanism at elevated temperature 
which induces the decomposition of the gas phase precursor. The nanowire diameter is primarily 
determined by the size of catalyst particle and the length is basically proportional to reaction 
time.
85,86
 Nanowire doping can be easily realized by introducing vapor phase dopants like AsCl3, 
PCl3, PH3, and B2H6 at high temperature to tailor the electric property.
86,87
 Besides CVD, other 
bottom-up growth of silicon nanowire includes laser ablation,
88,89
 molecular beam epitaxy
90,91
 
and silicon monoxide evaporation,
92,93
 etc. Another popular silicon nanowire preparation 
approach that especially beneficial for microelectric application is called “top-down” technique. 
This is a procedure to accomplish both horizontal nanowire array synthesis and FET device 
fabrication at the same time with unique features of high uniformity and reproducibility.
94,95
 
Typically, e-beam lithography (EBL) is performed on a silicon on insulator (SOI) wafer with a 
50-80 nm thick silicon layer on the top of a 50-100 nm thick oxide layer to pattern the desired 
nanowire array structure, then silicon nanowire can be achieved after applying reactive ion 
etching on unpatterned area deep down to the oxide layer.
94,96
 This technique provide a lot of 
advantages over tradition bottom up nanowire synthesis discussed above, such as elimination of 
difference of each single nanowire, tunable nanowire length and diameter, and capability of large 
scale fabrication.  
Before the surface modification of silicon nanowire which directs further conjugation of 
receptor molecules for biosensing, the nanowire is always treated with water-vapor plasma to 
clean sample surface as well as generate hydroxyl-terminated hydrophilic surface.
96
 Then 
crosslinkers such as 3-mercaptopropyltrimethoxysilane (MPTMS),
96
 trimethyloxysilane 
aldehyde,
94
 3-aminopropyltriethoxysilane (APTES)
97
 are applied to expose thiol, aldehyde,  
95 
 
respectively to allow further functionalization. Nucleic acid probe modified nanowire can be 
applied for detection of DNA and specific  gene mutation.
98
 The sensitivity of this label-free 
DNA detection can be reached to one base mismatch discrimination in the concentration range of 
1 fM to 1 nM.
96,99
 Nanowire FET linked with antibody or aptamer has been exploited for sensing 
of antigen-specific T-cell immune response,
100,101
  cardiac biomarker with antibody,
97
 vascular 
endotherial growth factor,
102
 multiple cancer biomarkers from whole blood sample
103
 and 
eventually multiplex detection using nanowire array,
104
 and  the substitution of the reactive 
substrate in conventional enzyme-linked immunosorbent assay (ELISA) for quantitative protein 
sensing.
105
 Furthermore, detection of single virus with fluorescence labeling was realized using 
silicon nanowire FET integrated with microfluidic channel and the whole process was monitored 
by both electrical recording and optical microscopy, demonstrating the change of electrical signal 
happens simultaneously upon the contact between virus and nanowire surface.
106
 Also, neuronal 
signal can be collected by simply connecting dendrite and synapse to nanowire
107
 and this idea 
was further developed for mapping neural circuits in acute brain slice using high density array.
108
 
Based on traditional nanowire FET structure, a unique branch structure with a germanium 
nanowire probe pointing out from silicon nanowire transistor and vertical to the device plane was 
fabricated for intracellular recording of action potential.
109
 In addition, device fabrication can 
also be completed on flexible transparent polymer substrate to achieve better contact with sample 
and employed for continuously recording spontaneous heart beat.
110
  
 
4.2.2.4 Conducting polymer (CP) nanowire based biosensor 
Conducting polymer features in sp
2
 hybridized backbone in which π-conjugated structure can 
improve the band gap of the material towards semiconductor property. Several commonly 
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studied CPs are Polyaniline (PANI), Polypyrrole (PPy), Polythiophene (PT), Poly(3-
hexylthiophene) (P3HT) and Poly(3,4-ethylenedioxythiophene) (PEDOT). Anionic dopants that 
vary from small spherical to large polyionic which adjusted concentrations are always applied to 
modulate the conductivity of the polymer. Another factor influencing conductivity is π-
conjugation length which may differ from polymer chain length due defects such as improper 
linkage and branching. Also disorder of polymer formation describing the crystalline status can 
affect electrical property and sensing performance. Both defect and disorder usually occurs 
during synthesis and subsequent preparation procedures.
111
 There are four popular synthesis 
techniques for CP,
112
 dip-pen nanolithography,
113,114
 mechanical stretching,
115
 electrospinning
116
 
and template-directed electrochemical synthesis.
117
 
Since CP is rich in surface functionality groups according to the characteristic of different 
monomers, conjugation of receptor molecules can be relatively easy and direct. Antibody 
covalently conjugated Ppy and poly (pyrrolepropylic acid) (poly (PPA)) nanowires have been 
introduced to the detection of cancer marker and human serum albumin for early diagnosis of 
renal diseases, respectively.
118,119
 CP nanowire can also be integrated with other nano or bio 
material to enhance the immobilization of capturing molecules and sensor performance. For 
example, PANI nanowire network decorated with peroxidase-conjugated Au nanoparticle was 
fabricated for in-situ detection of ischemic cell.
120
 In addition, PEDOT has been employed to 
form hybrid nanowire structure with bacteria-infecting virus which can be easily conjugated with 
engineered recognizing polypeptide for protein detection.
121,122
  
 
4.2.2.5 Others  
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Carbon nanostructures with field-effect property, including carbon nanotube (CNT) and 
graphene, have drawn extensive interest worldwide dramatically during the recent years for the 
potential application of energy storage, microelectronics, chemical and bio-sensing, and template 
for other synthesis.
123,124
 CNTs are composed entirely from sp
2
 carbon bonding and can be 
divided to single wall (SWNT) and multiwalled (MWNT). The electrical property of CNT is 
majorly determined by atomic arrangement (chirality) and diameter. Graphene is a two 
dimensional material with layers consist of carbon atoms in six-member ring arrangement. It can 
be considered as the fundamental building element for all carbon structures including fullerene, 
CNT and graphite.
124
 During biosensing of CNT and graphene, ssDNA probes can be 
immobilized on the material surface non-covalently through π-stacking of nucleic acid base and 
subject to DNA detection.
125,126
 Also, the carbon can be oxidized to provide carboxyl groups for 
further functionalization of receptor molecules such as antibodies for antigen and cell 
detection.
127,128
 In addition, 1-pyrenebutanoic acid succinimidyl ester with large π-conjugation 
structure is also frequently used as the linker between carbon surface and antibody.
 127,129
 
Among group III/V compounds, GaN nanowire has been utilized for DNA detection. The 
nanowire surface was first modified with (3-mercaptopropyl) trimethoxysilane (MPTS) to 
expose thiol groups, and then covalently linked with DNA probe for detection through nucleic 
acid hybridization. 
130
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Chapter V: Indium Oxide Nanowire Based Field-Effect Transistor for 
Biosensing 
 
5.1 Introduction 
In recent years, field-effect devices, such as semiconductor nanowire based transistors for 
highly selective and ultrasensitive biological detections, have been extensively studied.
1-7
 These 
devices are designed to capture targeting agents and their field effect property which allows the 
detection of bio-agents with minimized unspecific binding and noise-signal ratio through 
antibody-antigen interaction, enzyme-substrate interaction, hydrogen bond between nucleic acid 
chain, and other specific binding reactions available among bio-molecules. These interactions on 
the surface of transistors play the role of gate voltage change and therefore result in conductance 
differences which can be easily recorded using a conventional source meter. The captured agents 
in biosensors include antibodies, oligonucleotides, enzymes, small ligands, etc. 
As one of the most widely used semiconducting nanomaterials, indium oxide (In2O3) 
nanowire has shown its promising chemical-gating capacity in gas-sensing for toxic gases such 
as nitrogen dioxide and ammonia.
8
 Later, this gate-effect phenomenon was further demonstrated 
by conjugating small organic molecules and bio-agents
9,10
 and performed a series detection of 
single-strand DNA sequence,
11
 prostate-specific antigen,
12
 and virus capsid protein
13
, which 
indicate In2O3 nanowires as a very promising semiconductor nanomaterial for practical 
applications in biological sensing. 
In this chapter, we fabricated and characterized In2O3 nanowires as field effect biological 
sensors. A toxic protein ricin, known as inducing severe allergic reactions and death, is detected 
by our transistors through its engineered antibody. The FETs can be employed to build a 
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potential platform for biosensors for ricin detection with high sensitivity and selectivity. Also, to 
the best of our knowledge, so far, no study has been reported about using fluorescence imaging 
to investigate the binding between antibody and nanowire to ensure the binding efficiency and 
blocking agent efficiency, as well as to eliminate the non-specific interaction between antigen 
and nanowire surface. Herein, a series of experiments were conducted using engineered antibody 
to capture fluorescence labeled ricin and the laser confocal microscopy images were subjected to 
qualification analysis. 
 
5.2 Experimental 
5.2.1 Material and chemicals. Indium arsenide (InAs, 99.9999%) was purchased from Alfa 
Aesar. Acetone (99.5%) and isopropyl alcohol (99.5%) were purchased from EMD Chemical. 
Absolute ethanol was purchased from AAPer Alcohol and Chemical Co. Positive electron beam 
resist Poly(methyl methacrylate) 495 PMMA A4 and MIBK/IPA 1:3 developer were purchased 
from MICROCHEM. Silicon wafer with (100) orientation was purchased from University Wafer. 
Phosphate buffer saline (PBS, 10x stock solution), Tween-20, bovine serum albumin (BSA, 96%) 
were purchased from Sigma-Aldrich. Fluorescence labeled transferring, ricin and antihuman IgG, 
and engineered antibodies were all obtained from Dr. Seth Pincus’s laboratory in Research 
Institute for Children at Children’s Hospital New Orleans, and freshly diluted to target 
concentration with PBS prior to use. Aqua-mount slide mounting media was purchased from 
Thermo Scientific. 
 
5.2.2 Synthesis of semiconductive In2O3 nanowire. In2O3 nanowires were synthesized through 
chemical vapor deposition (CVD) approach which was modified based on a fast-heating-vapor-
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trapping method.
14
 The silicon substrate for nanowire growth was prepared by depositing a layer 
of gold nanoparticles, with approximate thickness of 5 nm, by using the Cressington 308R 
coating system. The InAs pieces were first gently ground into fine powder, and then transferred 
to an alumina crucible boat, with silicon substrate placing close to the top with the gold 
nanoparticle layer facing downward. The crucible boat was then placed in a small quartz test 
with a closed end, and the whole assembly was settled in a 2-inch quartz tube which was 
installed in a Lindburg/Blue tube furnace with vacuum pump and argon connection, but outside 
the heating area. The tube was pumped down to vacuum lower than 1 torr and filled with argon. 
This pump-fill process was repeated for several cycles to completely remove the oxygen in the 
system. Then the argon flow was reduced to 100 sccm, and the tube was heated to 550°C. Under 
a pressure of 1 atm, the crucible boat was moved to the center of the heating area via a magnet, 
and the reaction started immediately. After the reaction, the tube furnace was naturally cooled 
down, and the nanowire sample was examined by Carl Zeiss 1530 VP field emission scanning 
electron microscope (FESEM)) and JEOL 2010 transmission electron microscope (TEM). 
 
5.2.3 Single In2O3 nanowire device fabrication using bottom-up procedure. Silicon wafer with 
400-nm-thick thermal oxide film, which served as a substrate and back-gate in the device 
fabrication, was patterned with electrodes and diced into chips. The as-grown nanowires were 
carefully scratched off from the growth substrate and suspended in ethanol by sonication, then 
deposited on the silicon chip. After coated by PMMA through spin-coating (P6700 spin coater), 
electrodes on both ends of the nanowires were patterned through e-beam nanolithography 
(converted e-beam writing system using Carl Zeiss 1530 VP field emission scanning electron 
microscope (FESEM)), and the Ti/Au electrodes (source-S and drain-D) were deposited through 
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a Lesker PVD 75 electron beam evaporation system. Lastly, the chip was immersed in acetone 
overnight to remove the PMMA and lift-off metallic film. 
 
5.2.4 Device measurement. Copper leads were applied to the as-fabricated nanowire device 
using silver paste, and source and drain electrodes were connected to a Keithley 2400-C 
sourcemeter to obtain current-voltage (I-V) curve. BK Precision DC regulated power supply was 
used to provide gate voltage in the investigation of field-effect transistor property. 
 
5.2.5 Biological detection of ricin. Phosphate buffer saline (PBS, pH=7.4, 10 mM phosphates, 
137 mM NaCl, 2 mM KCl) and high purity water (HPLC grade) were purchased from Aldrich. 
Surface cleaning of In2O3 NW devices was achieved by submerging in acetone, ethanol, and hot 
water for 5 min each and then dried with nitrogen. The ricin samples with different concentration 
(maximum concentration is: antibody 0.03 mg/ml, and antigen 0.01 mg/ml) were made in PBS 
buffer solution. During the measurements, water, PBS buffer, and ricin samples were introduced 
into microfluidic channel through inlet and outlet in sequence, and the conductance of the NW 
was recorded under ambient conditions. 
 
5.2.6 Incubation procedure of In2O3 nanowire with biological species. As described in the 
previous chapter, In2O3 nanowire was first synthesized using CVD method then scratched off 
from the substrate and dispersed in water. An identical volume of the nanowire dispersion was 
dropped on cover slips with 8 mm diameter and 0.150 mm thickness and dried in air. Then the 
cover slips were transferred to a 48-well plate, facing up, and rinsed with 1 ml of 1x PBS one 
time before the first chemical/bio-species solution was applied. Solutions were then added in the 
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indicated order with four times of rinsing (water, PBS or PBS with 0.1% Tween-20, 1 ml/rinse) 
in between. After the last step and washing using PBS, the cover slips are sealed on glass slides 
using Aqua-mount and dried in the dark. 
 
5.2.7 Characterizations. A Carl Zeiss 1530 VP field emission scanning electron microscope 
(FESEM) and JEOL 2010 LaB6 transmission electron microscope (TEM) at an accelerating 
voltage of 200kv was used to examine the morphologies and sizes of the nanowire. 
 
5.3 Result and discussion 
5.3.1 Device fabrication of In2O3 nanowire based field-effect transistor 
5.3.1.1 In2O3 nanowire synthesis. The synthesis of semiconducting In2O3 nanowires was 
performed using chemical vapor evaporation method (CVD).
14
 As shown in Figure 5.1 (a), the 
reaction assembly consisted of precursor, substrate, crucible boat, and quartz test tube. The 
purpose of using this relatively complicated setup comparing to conventional CVD is to 
concentrate the InAs and In2O3 vapor as much as possible and prevent it from being disturbed 
and diluted by argon flow, therefore the density and yield of nanowires can be increased. The 
furnace tube was first pumped to vacuum and inflated with argon. This pump-inflate cycle was 
repeated multiple times in order to remove all other gas. After temperature rise to 550°C, the 
reaction assembly (part (1)-(4) in Figure (a)) was pushed to the central heating area. High purity 
InAs was selected as the reaction precursor under 1 atm argon environment. It vaporized rapidly 
due to the sudden heat, reacted with trace amounts of oxygen in the furnace tube, oxidized into 
In2O3, and eventually formed nanowires upon contact with the silicon substrate which was 
deposited with Au nanoparticle as the catalyst. Minority part of InAs stayed unoxidized and 
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remained in the product, while the arsenic served as a dopant in the n-type semiconducting 
nanowire. The amount of dopant was primarily controlled by the concentration of oxygen in the 
furnace tube. More cycles of pump-inflate of argon before the rising of furnace temperature can 
help further reduce the oxygen and increase degree of doping, which is favorable for obtaining 
semiconductors with higher conductivity. 
 
Figure 5.1 (a) schematics for the synthesis of In2O3 nanowires: (1)InAs precursor, (2) silicon 
substrate, (3)alumina crucible boat, (4)quartz test tube, (5)2-inch furnace tube and (6)furnace 
heating coil, (b) SEM and (c) TEM image of as-prepared In2O3 nanowires. 
 
As longer nanowires are more convenient for e-beam lithography during the device 
fabrication process, the synthesis of In2O3 nanowires was conducted for at least 12 hrs to achieve 
better length. The nanowire was then directly examined by SEM on the original growth substrate 
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as shown in Figure 5.1 (b). Average length was around 5 microns with some of them above 10 
microns, and the diameter various from 20 to 50 microns (Figure 5.1 (c)). Also, the nanowire 
growth exhibited high density which is also preferred for device fabrication. 
 
5.3.1.2 Device fabrication. As-synthesized In2O3 nanowire (NW) was removed from the growth 
substrate, suspended in ethanol by sonication and deposited onto doped Si wafers with 600-nm-
thick thermal oxide film and electrode pattern. Then Ti/Au electrodes were deposited on the ends 
of the NWs by electron beam lithography, metal evaporation, and liftoff process. For the purpose 
of bio-sensing application, the NW device was passivated with PMMA which only exposed the 
FET channel. Then the device was integrated with microfluidic channels for convenient bio-
agent injection and detection. The procedure is illustrated in Scheme 5.1. 
 
 
Scheme 5.1 Device fabrication procedure of In2O3 nanowire field-effect transistor using bottom-
up method.  
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An SEM image of as-fabricated NW device after metal deposition and lift-off is shown in 
Figure 5.2 (a). Single NW is bonded between two electrodes about 2 µm apart through e-beam 
lithography. After being connected to the sourcemeter, the UV response of the semiconductor 
device was investigated and recorded in a dark room. As a characteristic property of 
semiconducting materials, UV exposure can increase the density of charge carriers, therefore 
enhancing the conductivity. As seen in Figure 5.2 (b), under source-drain voltage Vds=1.0 V, the 
current, which representing conductivity of nanowire, increases simultaneously upon the 
application of UV light and reduces in a steep manner while UV is removed. The current is able 
to recover close to the original status and the procedure is repeatable multiple times. This 
sensitive UV response confirms that the as-synthesized In2O3 nanowire is indeed a 
semiconductor. 
 
Figure 5.2 (a) SEM image of as-fabricated In2O3 NW device and (b) UV response of single NW 
semiconducting transistor, arrows represent the points that UV was applied. 
 
5.3.1.3 Device measurement. The field-effect transistor property of the In2O3 NW was studied. 
Different biases were applied through the back-gate at the bottom of the device and a series of 
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current-voltage (I-V) curves between the source and drain were recorded in dry air conditions. 
Being an n-type semiconductor which has electrons as charge carriers, the In2O3 nanowire shall 
respond to gate voltage change in a positive manner. Positive gate voltage can attract negative 
charge carriers (electrons) to move and concentrate as the gate area, therefore forming a 
conductive channel between the source and drain, while negative gate voltage repels the 
electrons and doesn’t significantly change the distribution of the electrons. As shown in Figure 
5.3 (a), the slope of the I-V curves, which represents the conductivity of the NW, increases 
gradually as the gate voltage changes from -14.9 V to 24.9 V. The result can be exhibited more 
clearly by extracting the current under a fixed source-drain voltage (Vds=1.0 V) of all the I-V 
curves to generate an Ids (source-drain current)-Vgs (gate-source voltage) curve as seen in Figure 
5.3 (b). The current of the NW device is lower than 10
-8
 A under negative gate voltage, and 
increases in a linear behavior under positive gate voltage with an improvement of an order as 
gate voltage changed from 0 to 24.9 V, suggesting an excellent transistor behavior in dry air. 
 
Figure 5.3 (a) I-V curves of as fabrication In2O3 NW transistor under a series of gate voltage. (b) 
Ids (source-drain current)-Vgs (gate-source voltage) curve under Ids=1.0 V. 
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Figure 5.4 (a) Schematic of the sensor dye – polymer fluid cap assembly (b) Completely 
assembled dice with fluidic cap, inlet and out let tube interconnect, and FET device.  
 
5.3.1.4 Microfluidic channel integration. Figure 5.4 (a) illustrates the principle arrangement of 
the FET biosensor device integrated with the microfluidic channel. The Si-based nanowire 
electrode chip is sealed with a polymer fluidic cap which allows for introduction of sample fluid 
into the cavity. Through selective binding targeting bio-agents such as antigens to the nanowires, 
a change in electrical signal from the nanowires can be induced, which can be registered for the 
presence of specific molecules in the fluid. The electrode pattern is covered with PMMA layer, 
leaving only an In2O3 nanowire window area accessible to fluids carrying biological samples 
across the electrode area. Figure 5.4 (b) is a top view of the integrated device, showing the 
assembled microfluidic-channel-on-transistor chip with the sample inlet and outlet pipes ready 
for surface modification and bio-detection.  
 
5.3.1.5 Preliminary detection of ricin. Prior to biological detection, an I-V property test was 
performed under 1.0 V source-drain voltage in dry air and the source-drain current remained 
stable during a 16-hour-test, which verified that the transistor was robust and suitable for long 
term continuous usage. The bio-agents, ricin-A-chain (RAC) and its antibody were then 
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introduced to test the performance by monitoring the conductance of the FET device. The 
antibody used here is modified by adding 6X-Histidine tag for metal chelation to the C-terminus 
of the antibody heavy chains to get better affinity with the nanowire surface.  
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Figure 5.5 (a) Water, buffer and ricin biological responses of a typical In2O3 FET device. (b)  The 
enlarged response curve in the blue box in (a). Ab- antibody and Ag- antigen. 
 
At first, water was  injected into the inlet (the current monitored over time under Vds = 1.0V 
and Vg = 0V), and the current decreased immediately as shown in Figure 5.5 (a), and then 
returned to the original state once water was removed by air flow. This may be explained as the 
partially negatively charged oxygen atoms in water molecules have higher affinity with In2O3 
surface in the form of metal-oxygen conjugate bond than hydrogen atoms, hence providing extra 
electrons on nanowire surface and inducing the conductance to drop. Then a phosphate buffer 
saline (PBS, pH=7.4) solution was introduced and similar results were obtained because of 
additional conjugation effort between In2O3 and negative charged phosphate. As the solution of 
ricin (0.01 mg/L) and its antibodies (0.03 mg/L) were introduced to the device, the current 
decreased immediately because of PBS, and then increased gradually as a slower response to 
ricin and antibody. Dilution of this antigen-antibody solution was performed for several times to 
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achieve 1/2, 1/4, 1/8… of original concentration and injected into the microfluidic channel. As 
shown in Figure 5.5 (b), the current reduced in a stepwise manner after each injection, which 
indicates concentration dependent sensitivity. Finally, the current increased again once the ricin 
solution with high concentration was applied. This current/conductance change compared with 
that of PBS of the nanowire exposure to solution can be attributed to the charging status of bio-
agents. According to the calculation targeting on the amino acid sequence of ricin A chain and its 
antibody, the ricin-antibody complexes appear to have a theoretical isoelectric point (pI) around 
8.6 and carry positive charge in a pH 7.4 PBS buffer, and ricin A chain, has a theoretical pI 
(isoelectric point) around 6.14, and carry negative charge in a pH 7.4 PBS buffer. While binding 
on the In2O3 nanowire surface, they will act as gate voltage and lead to the change of carrier 
density in the FET. This preliminary text of ricin indicates that the In2O3 NW device is sensitive 
to the change of charge from bio-species with different concentration, and it is a promising 
material for more sophisticated bio-sensing detection. 
 
5.3.2 Nonspecific binding of between bio-species and In2O3 nanowire 
5.3.2.1 Engineered antibody. The molecule of antibody consists of a constant portion which is 
common among all antibodies from one species, and a variable portion which is designated to 
capture specific antigens, as shown in Figure 5.6 (a). The antibody molecules can only be 
attached to the NW through weak interaction forces such as Van Der Waals forces, electrostatic 
forces that majorly depend on the amino acids located on the surface of the antibody, therefore 
the efficiency of binding cannot be guaranteed. Even though binded to the NW, the antibody 
molecules are in random orientation in which the antigens binding site is not perfectly exposed. 
By adding engineered tags of 6 amino acid sequences at the end of heavy chains, the antibody is 
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capable of binding to the nanowire more efficiently with an oriented position which exposes the 
antigen binding site. Histidine (Figure 5.6 (b)) is selected for building the engineered tag because 
of high affinity between the imidazole groups and metal/metal oxide materials through chelation 
bond, and no complexity from covalent conjugation using crosslinking reactions.  
 
Figure 5.6 (a) schematics of antibody molecule with engineered tag, (b) molecular structure of 
histidine, (c) theoretical arrangement of antibody, antigen and blocking agent BSA on NW during 
detection. 
 
5.3.2.2 Quantification of binding efficiency between nanowire, antibody and antigen. The 
entire ricin detection procedure was simulated by using fluorescence labeled agents in order to 
confirm successful antigen immobilization and avoid non-specific binding between nanowire and 
bio-molecules as illustrated in Figure 5.6 (c). In2O3 nanowires were first deposited on cover slips 
in 48-well plates, then blocking agent BSA, antibodies and Alexa-594 nm conjugated antigens 
were applied in sequence. The samples were then sealed and analyzed under Zeiss LSM 510 
laser confocal microscopy to obtain image quantification data.  
To test the binding efficiency of engineered histidine tagged antibody, the nanowire samples 
were first treated with different antibodies. ChRAC and ChRAC-His are natural anti-ricin 
antibodies and engineered antibodies with a histidine tag, respectively. And 7B2 is an irrelevant 
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antibody which worked as the negative control. After that, bovine serum albumin was used as 
blocking agent to prevent unspecific binding between nanowire and antigen. At last, Alexa-594 
nm conjugated ricin and irrelevant antigen transferring which served as control, were applied.  
 
Figure 5.7 Laser confocal microscopy images of In2O3 nanowires treated with different antibody 
and fluorescence labeled antigen. Insert percentages are the colocalisation rate between red pixel 
(antigen) and dark pixel (nanowire). 
 
Laser confocal microscopy images (Figure 5.7) are shown with colocalisation percentage 
between red pixel (antigen) and dark pixel (nanowire), which indicates the successful binding of 
both antibody on NW and antigen on antibody. As mentioned before, since natural type CHRAC 
antibody can only bind to NW in low efficiency and the orientation is not optimized, few antigen 
molecules can be captured on NW as seen in Figure 5.7 (a), the colocalisation rate between NW 
and antigen is 0%. The ChRAC-His—ricin pair Figure 5.7 (b) yielded the highest colocalisation 
compared to the controls (Figure 5.7 (c)-(f))which indicates that engineered ChRAC-His 
antibody is able to bind on the nanowire surface effectively in favored orientation to capture the 
targeted antigen specifically.  
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Figure 5.8 Laser confocal microscopy images of In2O3 nanowires treated CHRAC or CHRAC-
His antibody and fluorescence labeled ricin in different order of BSA and antibody. Inserts are 
average red fluorescence intensity of colocalized red and black pixels. 
 
The order of adding BSA and antibody was also investigated. In most conventional bio-
assays which involve antigen-antibody interaction, BSA is applied between antibody and antigen 
to block the uncovered area, in order to ensure not only sufficient binding of antibody on 
substrate, but also elimination of non-specific binding between antigen and substrate. In our 
experiment, two different adding orders, BSA-antibody-antigen and antibody-BSA-antigen were 
studied. A sample with no antibody (Figure 5.8 (c)) was prepared as a control. It was discovered 
unexpectedly that adding BSA before the engineered CHRAC-His antibody (Figure 5.8 (b)) gave 
a better efficiency on capturing antigen than the one with BSA added after antibody just like 
normal bio-assay (Figure 5.8 (d)). It is most likely caused by interaction between BSA and 
CHRAC-His molecules through exposed amino acid sequence. The detailed reason of this 
phenomenon is still under investigation. The sample with the sequence CHRAC-BSA-antigen 
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(Figure 5.8 (d)) gave the second highest intensity, but it is obvious from the image that a lot of 
red pixels are not colocalized with black pixel, suggesting lower blocking efficiency of BSA. 
 
Similar procedures were performed to further confirm the immobilization of histidine-tagged 
antibody using secondary antibody. Phycoerythrin (PE) conjugated anti-human IgG, which 
specifically binds to human antibodies, was employed in the place of antigen, and the result was 
compared with the samples using fluorescence labeled ricin. Laser confocal microscopy images 
are shown in Figure 5.9 with average intensity of emission (n=5 images per sample) from 
colocalized red and dark pixels. As seen in Figure 5.9 (e), PE labeled anti-human IgG was able to 
bind to CHRAC-His and present red fluorescence with higher intensity that colocalized with NW, 
compared to the sample with only natural type CHRAC (Figure 5.9 (c)) and no antibody (Figure 
 
Figure 5.9 Laser confocal microscopy images of In2O3 nanowires treated CHRAC or CHRAC-
His antibody first, and then applied with either fluorescence labeled ricin or anti-human IgG. 
Sample (c) and (d) are without antibody and used as control.  Inserts are average red 
fluorescence intensity of colocalized red and black pixels with standard deviation (n=5 images 
taken for each sample). 
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5.9 (f)). This result further confirms that the engineered CHRAC-His antibody is able to bind to 
NW surface and remain functional. 
 
Figure 5.10 Slicing scan with 0.5 µm interval of single NW treated with CHRAC-His and 
fluorescence labeled ricin, showing the position of the bio-molecules. 
 
To ensure the antibody-antigen interaction did happen on the surface of NW instead of 
simply overlapped with NW on the fluorescence images, slicing scan along z axis with 0.5 µm 
intervals was applied on a single nanowire after ChRAC-His binding and ricin-Alexa-594 nm 
treatment. As shown in Figure 5.10, red fluorescence that comes from labeled ricin is located all 
around the NW in the slicing image of middle session, but diminished in the image of top and 
bottom sessions, indicating that the ricin molecules are indeed captured on the surface of 
nanowire.  
 
5.4 Conclusion 
In this chapter, semiconductive In2O3 nanowire was synthesized using CVD method. Back-
gate device was fabricated through bottom up method and integrated with microfluidic channel 
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for bio-species detection. The nanowire device exhibits good field-effect property and is 
sensitive to the concentration change of antigens during the preliminary detection of ricin. At the 
same time, fluorescence label antigen ricin was used for simulating the entire bio-detection 
procedure on nanowire deposited on cover glass and examined by laser confocal microscopy. 
The result confirms that the engineered antibody is able to bind on NW and capture antigens 
more effectively than the nature type antibody.  
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Chapter VI: Silicone Nanowire Based Field-Effect Transistor using Top-down 
Approach for Biosensing 
 
6.1 Introduction 
As mentioned in the previous chapter, In2O3 nanowires have been a promising 
semiconducting nanomaterial for biological sensing. However, the synthesis methods of In2O3 
nanowires, such as chemical deposition
1,2
  and laser ablation
 2
, cause it to be difficult to control 
nanowires with uniform morphology and FET properties. Also, there is always an issue of poor 
quality FET fabricated through a bottom up technique, such as loosening electrode contacts. In 
addition, to perform selective detections, assembling nanowires in an ordered array is a big 
challenge for many research groups. Therefore, more homogenous nanowires and robust device 
architectures need to be explored. One effective solution is to utilize a top-down method 
(microelectronic device processing technique) to fabricate nanowire FET device,
3
 in which the 
nanowire size and location can be predetermined through a precise lithography process which 
doesn’t re uire ‘manual’ operation of nanowire alignment, giving a robust architecture.  
On the other hand, single nanowire FET detection cannot be the conclusive measurement for 
the existence and concentration of bio-agents because it is neither capable of performing parallel 
control experiments nor selective sensing for a mixture sample which is necessary in biological 
studies. As silicon based FET has already shown its potential bio-sensor ability,
4-8
 we are trying 
to fabricate highly repeatable and robust multiplexed silicon nanowire FET through a top-down 
method for a systematic detection of different bio-species. 
 
6.2 Experimental  
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6.2.1 Materials and chemicals. Thin film silicone on insulator (SOI) wafer with 52.8 nm thick 
silicone layer and 156.4 nm thick oxidize layer was purchased from SIMGUI Technology. SOI 
wafer with a 280 nm silicon layer on top and a 380 nm oxide layer buried was purchased from 
University Wafer. Acetone (99.5%) and isopropyl alcohol (99.5%) were purchased from EMD 
Chemical. Absolute ethanol was purchased from AAPer Alcohol and Chemical Co. Positive 
electron beam resist Poly(methyl methacrylate) 495 PMMA A4, MIBK/IPA 1:3 developer and 
chromium etchant were purchased from MICROCHEM. 
 
6.2.2 Device fabrication. The SOI wafer was first patterned with electrodes, using photoresist, 
and then diced to individual chips. Nanowires with demanded thickness and array shape were 
written through e-beam nanolithography on a spin-coated PMMA layer on the wafer. After 
PMMA etching, the patterned area is covered by a chromium mask with 30 nm thickness through 
metal deposition (Lesker PVD 75 electron beam evaporation system) and lift-off (in acetone 
overnight). Then the wafer is applied to reactive ion etching (RIE) in CF4 gas to get the exposed 
silicon layer removed until reaching the silicon dioxide layer underneath to form silicon 
nanowires in the Cr covered area. After Cr mask removal, the as-designed silicon nanowire array 
is achieved.
3
 
 
6.2.3 Device measurement. Copper leads were applied to the as-fabricated nanowire device 
using silver paste and copper leads to connect source and drain electrodes to a Keithley 2400-C 
sourcemeter to obtain the current-voltage (I-V) curve. BK Precision DC regulated power supply 
was use to provide gate voltage in the investigation of field-effect transistor property. 
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6.3 Result and discussion 
6.3.1 Device fabrication. As shown in Scheme 6.1, silicon-on-insulator (SOI) wafers, with a 280 
nm silicon layer on top and a 380 nm oxide layer buried, covered with PMMA are used to pattern 
the configuration of the desired silicon nanowire array by electron-beam lithography. After 
developing of PMMA, the patterned area is covered by a chromium mask through metal 
deposition and lift-off. Then the wafer is applied to reactive ion etching (RIE) to get the exposed 
silicon layer removed until reaching the silicon dioxide layer underneath to form silicon 
nanowires in the Cr covered area. After Cr mask removal, the as-designed silicon nanowire array 
is achieved.
3
 The morphology of the as-fabricated silicon nanowire array is shown in Figure 6.1 
and the wafer will be integrated with microfluidic channel. 
 
Scheme 6.1 Procedure of top-down method to fabricate multiplexed silicon nanowire FET 
device array for biosensor. 
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Figure 6.1 SEM images of nanowire array after removing Cr mask. The width of Si NW 
is about 300 nm. 
 
 
Figure 6.2 (a) SEM image of single silicon nanowire device, (b) Current (I)-voltage (V) curve of 
single silicon nanowire device. 
 
6.3.2 FET property. The basic electrical properties of the as fabricated single, silicon nanowire 
device (Figure 6.2(a)) was investigated by measuring current (I)-voltage (V) curve as shown in 
Figure 6.2 (b). The I-V curve of a single nanowire shows very good conductivity with a 
conductance around 0.12 mS. However, the devices did not exhibit obvious gate-voltage 
dependence when applying various gate voltages. There are two factors that may contribute to 
the disappearance of the gate-effect. One is that the quality of the Si layer and insulator layer are 
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worsened during the fabrication process. It can be seen under SEM that there are some holes in 
insulator layer and defects on Si nanowires, which may affect the electrical properties of the 
device. In addition, current leaking was observed within the insulator layer which might have an 
effect on the field-effect property. Another reason is the carrier concentration in silicon layer on 
the insulator. The outstanding conductance indicates high carrier density, which may overwhelm 
the contribution of gate-voltage. We are continuing to optimize the fabrication process to obtain 
the Si nanowire device with gate effect for biosensor applications in the following work. 
 
Figure 6.3 Electrode pattern design of SOI wafer (a) wafer size arrangement, (b) detailed 
measurement on single dice, (c) size of electrode tip area for nanowire fabrication. 
 
20um
40um
(a) (c)
(b)
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6.3.3 Design of wafer size electrode pattern. To maximize the usage of each 4-inch SOI wafer, 
the previous wafer-size electrode pattern design which only carries 16 dices per wafer was 
revoked and a more efficient pattern has been developed as shown in Figure 6.3. In this design, a 
total number of 64 dices can be achieve (Figure 6.3 (a)) with electrode pads more separated from 
each other for convenient lead attachment (Figure 6.3 (b)). The electrode tips are 20 µm in width 
with 40 µm gap (Figure 6.3 (c)) to suit the working magnification and resolution during e-beam 
lithography and allows the length of written nanowires to be up to 40 µm.  
 
Figure 6.4 Surface modification of silicon nanowire FET device using APTES. 
 
After the platform of silicon nanowire device using the top-down method was established, 
this technique can be employed to simultaneous multiplex detection for antigens due to the 
excellent uniformity between different nanowire devices. By starting this experiment, surface 
functionalization will be performed on silicon nanowire by using 3-aminopropyltriethoxysilane 
(APTES), leaving reactive amine groups for further functionalization
4
 as shown in Figure 6.4. 
After that, different engineered antibodies will be immobilized on individual silicon nanowire 
devices through covalent binding on the same SOI wafer to achieve multiplexed selective 
detection as shown in Figure 6.5. 
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Figure 6.5 Surface modifications for selective detection, showing simultaneous multiplex 
detection. 
 
6.4 Conclusion 
In this chapter, e-beam lithography techniques were employed for top-down fabrication of 
silicon nanowires on SOI wafers for bio-sensing application. Investigation is still undergoing 
based on newly designed electrode patterns and SOI wafers with better quality to optimize the 
parameters during device fabrication in order to achieve the qualified field effect transistor 
property for multiplexed biosensor detection. 
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